Mouse	B-DNA
interleukin-2	I-DNA
receptor	I-DNA
alpha	I-DNA
gene	I-DNA
expression	O
.	O

Interleukin-1	B-protein
and	O
interleukin-2	B-protein
control	O
transcription	O
via	O
distinct	O
cis-acting	B-DNA
elements	I-DNA
.	O

We	O
have	O
shown	O
that	O
interleukin-1	B-protein
(	O
IL-1	B-protein
)	O
and	O
IL-2	B-protein
control	O
IL-2	B-DNA
receptor	I-DNA
alpha	I-DNA
(	I-DNA
IL-2R	I-DNA
alpha	I-DNA
)	I-DNA
gene	I-DNA
transcription	O
in	O
CD4-CD8-	B-cell_line
murine	I-cell_line
T	I-cell_line
lymphocyte	I-cell_line
precursors	I-cell_line
.	O

Here	O
we	O
map	O
the	O
cis-acting	B-DNA
elements	I-DNA
that	O
mediate	O
interleukin	O
responsiveness	O
of	O
the	O
mouse	B-DNA
IL-2R	I-DNA
alpha	I-DNA
gene	I-DNA
using	O
a	O
thymic	B-cell_line
lymphoma-derived	I-cell_line
hybridoma	I-cell_line
(	O
PC60	B-cell_line
)	O
.	O

The	O
transcriptional	O
response	O
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
to	O
stimulation	O
by	O
IL-1	B-protein
+	O
IL-2	B-protein
is	O
biphasic	O
.	O

IL-1	B-protein
induces	O
a	O
rapid	O
,	O
protein	O
synthesis-independent	O
appearance	O
of	O
IL-2R	B-RNA
alpha	I-RNA
mRNA	I-RNA
that	O
is	O
blocked	O
by	O
inhibitors	O
of	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

It	O
also	O
primes	O
cells	O
to	O
become	O
IL-2	B-protein
responsive	O
and	O
thereby	O
prepares	O
the	O
second	O
phase	O
,	O
in	O
which	O
IL-2	B-protein
induces	O
a	O
100-fold	O
further	O
increase	O
in	O
IL-2R	B-RNA
alpha	I-RNA
transcripts	I-RNA
.	O

Transient	O
transfection	O
experiments	O
show	O
that	O
several	O
elements	O
in	O
the	O
promoter-proximal	B-DNA
region	I-DNA
of	O
the	O
IL-2R	B-DNA
alpha	I-DNA
gene	I-DNA
contribute	O
to	O
IL-1	B-protein
responsiveness	O
,	O
most	O
importantly	O
an	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
conserved	O
in	O
the	O
human	B-DNA
and	I-DNA
mouse	I-DNA
gene	I-DNA
.	O

IL-2	B-protein
responsiveness	O
,	O
on	O
the	O
other	O
hand	O
,	O
depends	O
on	O
a	O
78-nucleotide	B-DNA
segment	I-DNA
1.3	O
kilobases	O
upstream	O
of	O
the	O
major	B-DNA
transcription	I-DNA
start	I-DNA
site	I-DNA
.	O

This	O
segment	O
functions	O
as	O
an	O
IL-2-inducible	B-DNA
enhancer	I-DNA
and	O
lies	O
within	O
a	O
region	O
that	O
becomes	O
DNase	B-protein
I	I-protein
hypersensitive	O
in	O
normal	O
T	B-cell_type
cells	I-cell_type
in	O
which	O
IL-2R	B-protein
alpha	I-protein
expression	O
has	O
been	O
induced	O
.	O

IL-2	B-protein
responsiveness	O
requires	O
three	O
distinct	O
elements	B-DNA
within	O
the	O
enhancer	B-DNA
.	O

Two	O
of	O
these	O
are	O
potential	O
binding	O
sites	O
for	O
STAT	B-protein
proteins	I-protein
.	O

ThE	NULL
JourNaL	NULL
or	NULL
BroLocicat	NULL
CHEMISTRY	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

18	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

10743-10753	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Mouse	NULL
Interleukin-2	NULL
Receptor	NULL
a	NULL
Gene	NULL
Expression	NULL
INTERLEUKIN-1	NULL
AND	NULL
INTERLEUKIN-2	NULL
CONTROL	NULL
TRANSCRIPTION	NULL
VIA	NULL
DISTINCT	NULL
cis-ACTING	NULL
ELEMENTS*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
29	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
27	NULL
,	NULL
1995	NULL
)	NULL
Peter	NULL
Sperisent§	NULL
,	NULL
San	NULL
Ming	NULL
Wang+	NULL
#	NULL
1	NULL
,	NULL
Elisabetta	NULL
Soldaini	NULL
,	NULL
Maria	NULL
Plal	NULL
,	NULL
Corinne	NULL
Rusterholz	NULL
,	NULL
Philipp	NULL
Bucher	NULL
,	NULL
Patricia	NULL
Corthésy	NULL
,	NULL
Patrick	NULL
Reichenbach	NULL
,	NULL
and	NULL
Markus	NULL
Nabholz**	NULL
From	NULL
the	NULL
Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
(	NULL
ISREC	NULL
)	NULL
,	NULL
155	NULL
Chemin	NULL
des	NULL
Boveresses	NULL
,	NULL
CH-1066	NULL
Epalinges	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
and	NULL
IL-2	NULL
control	NULL
IL-2	NULL
receptor	NULL
a	NULL
(	NULL
IL-Z2Ra	NULL
)	NULL
gene	NULL
transcription	NULL
in	NULL
murine	NULL
T	NULL
lymphocyte	NULL
precursors	NULL
.	NULL

Here	NULL
we	NULL
map	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
mediate	NULL
interleukin	NULL
responsiveness	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
using	NULL
a	NULL
thymic	NULL
lymphoma-derived	NULL
hybridoma	NULL
(	NULL
PC60	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
IL-Z2Ra	NULL
gene	NULL
to	NULL
stimulation	NULL
by	NULL
IL-1	NULL
+	NULL
IL-2	NULL
is	NULL
biphasic	NULL
.	NULL

IL-1	NULL
induces	NULL
a	NULL
rapid	NULL
,	NULL
protein	NULL
synthesis-independent	NULL
appearance	NULL
of	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

It	NULL
also	NULL
primes	NULL
cells	NULL
to	NULL
become	NULL
IL-2	NULL
responsive	NULL
and	NULL
thereby	NULL
prepares	NULL
the	NULL
second	NULL
phase	NULL
,	NULL
in	NULL
which	NULL
IL-2	NULL
induces	NULL
a	NULL
100-fold	NULL
further	NULL
increase	NULL
in	NULL
IL-Z2Ra	NULL
transcripts	NULL
.	NULL

Transient	NULL
transfection	NULL
experiments	NULL
show	NULL
that	NULL
several	NULL
elements	NULL
in	NULL
the	NULL
promoter-proximal	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
contribute	NULL
to	NULL
IL-1	NULL
responsiveness	NULL
,	NULL
most	NULL
importantly	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
gene	NULL
.	NULL

IL-2	NULL
responsiveness	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
depends	NULL
on	NULL
a	NULL
78-nucleotide	NULL
segment	NULL
1.3	NULL
kilobases	NULL
upstream	NULL
of	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

This	NULL
segment	NULL
functions	NULL
as	NULL
an	NULL
IL-2-inducible	NULL
enhancer	NULL
and	NULL
lies	NULL
within	NULL
a	NULL
region	NULL
that	NULL
becomes	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
in	NULL
which	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
has	NULL
been	NULL
induced	NULL
.	NULL

IL-2	NULL
responsiveness	NULL
requires	NULL
three	NULL
distinct	NULL
elements	NULL
within	NULL
the	NULL
enhancer	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
are	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
STAT	NULL
proteins	NULL
.	NULL

Interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
is	NULL
a	NULL
growth	NULL
factor	NULL
for	NULL
antigen-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

IL-2	NULL
drives	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
high	NULL
affinity	NULL
receptor	NULL
that	NULL
consists	NULL
of	NULL
three	NULL
different	NULL
trans-membrane	NULL
proteins	NULL
,	NULL
IL-2	NULL
receptors	NULL
(	NULL
IL-2R	NULL
)	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
(	NULL
1	NULL
)	NULL
.	NULL

IL-2Ra	NULL
«	NULL
expression	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
extracellular	NULL
*This	NULL
work	NULL
has	NULL
been	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Swiss	NULL
National	NULL
Science	NULL
Foundation	NULL
and	NULL
the	NULL
Swiss	NULL
Cancer	NULL
League	NULL
(	NULL
to	NULL
M.	NULL
N.	NULL
)	NULL
and	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
ICSC-World	NULL
Laboratory	NULL
(	NULL
to	NULL
S.-M.	NULL
W.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
entered	NULL
into	NULL
the	NULL
GenBank	NULL
``	NULL
``	NULL
/EMBL	NULL
Data	NULL
Bank	NULL
under	NULL
accession	NULL
number	NULL
M16398	NULL
.	NULL

+	NULL
Contributed	NULL
equally	NULL
to	NULL
the	NULL
work	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
.	NULL

§	NULL
Present	NULL
address	NULL
:	NULL
Div	NULL
.	NULL

d'Immunologie	NULL
et	NULL
d'Allergie	NULL
,	NULL
CHUV	NULL
,	NULL
CH-1011	NULL
Lausanne	NULL
,	NULL
Switzerland	NULL
.	NULL

1	NULL
Present	NULL
address	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Biochemistry	NULL
,	NULL
Molecular	NULL
Biology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Northwestern	NULL
University	NULL
,	NULL
2135	NULL
N.	NULL
Campus	NULL
Dr.	NULL
,	NULL
Evanston	NULL
,	NULL
IL	NULL
60208	NULL
.	NULL

||	NULL
Present	NULL
address	NULL
:	NULL
Dept	NULL
.	NULL

Biologia	NULL
Cellular	NULL
,	NULL
Universitat	NULL
de	NULL
Girona	NULL
,	NULL
E-17071	NULL
Girona	NULL
,	NULL
Spain	NULL
.	NULL

**	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
ISREC	NULL
,	NULL
CH-1066	NULL
Epalinges	NULL
,	NULL
Switzerland	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
21	NULL
692	NULL
58	NULL
58	NULL
;	NULL
Fax	NULL
:	NULL
21	NULL
652	NULL
69	NULL
33	NULL
;	NULL
E-mail	NULL
:	NULL
Markus	NULL
.	NULL

Nabholz	NULL
@	NULL
isrec.unil.ch	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IL-2R	NULL
,	NULL
IL-2	NULL
receptor	NULL
;	NULL
5'-FR	NULL
,	NULL
5'-flanking	NULL
region	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcrip-tion	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidinedithiocarbamate	NULL
.	NULL

stimuli	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

It	NULL
thereby	NULL
controls	NULL
,	NULL
in	NULL
part	NULL
,	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

In	NULL
mature	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
IL-2Ra	NULL
synthesis	NULL
is	NULL
triggered	NULL
by	NULL
signals	NULL
from	NULL
the	NULL
antigen	NULL
receptor	NULL
.	NULL

In	NULL
antigen-activated	NULL
T	NULL
cells	NULL
,	NULL
IL-2	NULL
itself	NULL
is	NULL
required	NULL
for	NULL
prolonged	NULL
IL-2Ra	NULL
expression	NULL
(	NULL
3-9	NULL
)	NULL
.	NULL

In	NULL
early	NULL
CD4~CDS8~	NULL
thymic	NULL
T	NULL
cell	NULL
precursors	NULL
that	NULL
have	NULL
been	NULL
activated	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
and	NULL
a	NULL
calcium	NULL
ionophore	NULL
,	NULL
IL-1	NULL
synergizes	NULL
with	NULL
IL-2	NULL
to	NULL
increase	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
levels	NULL
and	NULL
surface	NULL
expression	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
occurs	NULL
mostly	NULL
through	NULL
changes	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
.	NULL

This	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
run-on	NULL
transcription	NULL
experiments	NULL
for	NULL
stimulation	NULL
by	NULL
phytohemagglutinin	NULL
,	NULL
IL-2	NULL
and	NULL
IL-1	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
and	NULL
confirmed	NULL
by	NULL
an	NULL
analysis	NULL
of	NULL
mice	NULL
carrying	NULL
a	NULL
mouse	NULL
IL-2Ra	NULL
5'-flanking	NULL
region/chloramphenicol	NULL
acetyltransferase	NULL
transgene	NULL
(	NULL
65	NULL
)	NULL
.	NULL

In	NULL
the	NULL
human	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
leukemia	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
,	NULL
however	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
resident	NULL
gene	NULL
had	NULL
not	NULL
been	NULL
well	NULL
characterized	NULL
(	NULL
13-20	NULL
)	NULL
.	NULL

Regulatory	NULL
elements	NULL
conferring	NULL
responsiveness	NULL
to	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
including	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
and	NULL
IL-1	NULL
were	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
proximal	NULL
segment	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
(	NULL
5'-FR	NULL
)	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
3	NULL
'	NULL
of	NULL
position	NULL
-390	NULL
,	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
elements	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
mapped	NULL
.	NULL

Work	NULL
in	NULL
our	NULL
laboratory	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
identification	NULL
of	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
(	NULL
65	NULL
)	NULL
that	NULL
in	NULL
transgenic	NULL
mice	NULL
the	NULL
segment	NULL
between	NULL
bp	NULL
-2539	NULL
and	NULL
+93	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
confers	NULL
on	NULL
a	NULL
reporter	NULL
gene	NULL
correct	NULL
cell	NULL
type	NULL
specificity	NULL
and	NULL
inducible	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
their	NULL
early	NULL
thymic	NULL
precursors	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
rodent	NULL
thymic	NULL
lymphoma-derived	NULL
cell	NULL
line	NULL
,	NULL
PC6O	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
to	NULL
define	NULL
the	NULL
regions	NULL
in	NULL
the	NULL
5'-FR	NULL
that	NULL
are	NULL
required	NULL
for	NULL
IL-1-	NULL
and	NULL
IL-2-inducible	NULL
expression	NULL
.	NULL

PC60O	NULL
cells	NULL
express	NULL
neither	NULL
CD4	NULL
nor	NULL
CD8	NULL
surface	NULL
markers	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
,	NULL
like	NULL
normal	NULL
CD4_-CD8~	NULL
thymocytes	NULL
(	NULL
10	NULL
)	NULL
,	NULL
they	NULL
respond	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
by	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
.	NULL

Previous	NULL
work	NULL
had	NULL
shown	NULL
that	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
the	NULL
2.5-kb	NULL
5'-FR	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
conferred	NULL
a	NULL
response	NULL
pattern	NULL
on	NULL
a	NULL
reporter	NULL
gene	NULL
that	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
«	NULL
genes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Interleukin	NULL
responsiveness	NULL
clearly	NULL
depended	NULL
on	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
analyzed	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
.	NULL

Experiments	NULL
using	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
an	NULL
antigen	NULL
specific	NULL
IL-2-dependent	NULL
T	NULL
cell	NULL
clone	NULL
confirmed	NULL
that	NULL
the	NULL
upstream	NULL
segment	NULL
was	NULL
crucial	NULL
for	NULL
correct	NULL
expression	NULL
of	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
recombinants	NULL
.	NULL
``	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
response	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
to	NULL
IL-1	NULL
+	NULL
IL-2	NULL
is	NULL
biphasic	NULL
,	NULL
and	NULL
that	NULL
this	NULL
reflects	NULL
a	NULL
bipartite	NULL
distribution	NULL
of	NULL
the	NULL
interleukin	NULL
response	NULL
elements	NULL
.	NULL

IL-1	NULL
responsiveness	NULL
is	NULL
mediated	NULL
by	NULL
several	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
,	NULL
which	NULL
includes	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
conserved	NULL
in	NULL
both	NULL
human	NULL
and	NULL
*	NULL
S.	NULL
Barangé	NULL
,	NULL
P.	NULL
Sperisen	NULL
,	NULL
and	NULL
G.	NULL
Plaetinck	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

10743	NULL
10744	NULL
mouse	NULL
genes	NULL
,	NULL
whereas	NULL
IL-2	NULL
responsiveness	NULL
depends	NULL
on	NULL
three	NULL
separable	NULL
8-12-nucleotide	NULL
elements	NULL
within	NULL
48	NULL
nucleotides	NULL
of	NULL
an	NULL
IL-2-responsive	NULL
enhancer	NULL
1.3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

This	NULL
segment	NULL
overlaps	NULL
with	NULL
a	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
detected	NULL
only	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
in	NULL
which	NULL
IL-2Ra	NULL
expression	NULL
has	NULL
been	NULL
induced	NULL
(	NULL
65	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Lines	NULL
and	NULL
Culture	NULL
Conditions	NULL
:	NULL
Cytokines	NULL
and	NULL
Inhibitors-The	NULL
PC60.21.14	NULL
cell	NULL
line	NULL
(	NULL
here	NULL
referred	NULL
to	NULL
as	NULL
PC6O	NULL
)	NULL
has	NULL
been	NULL
described	NULL
in	NULL
previous	NULL
publications	NULL
(	NULL
11	NULL
,	NULL
21-23	NULL
)	NULL
.	NULL

PC6O	NULL
(	NULL
G3	NULL
)	NULL
are	NULL
stable	NULL
transfectants	NULL
that	NULL
constitutively	NULL
express	NULL
a	NULL
cDNA	NULL
clone	NULL
encoding	NULL
the	NULL
human	NULL
IL-2Ra	NULL
chain	NULL
(	NULL
24	NULL
)	NULL
.	NULL

PC6O0	NULL
has	NULL
inherited	NULL
from	NULL
its	NULL
lymphoma	NULL
parent	NULL
the	NULL
CD4~CD8~	NULL
phenotype	NULL
(	NULL
22	NULL
)	NULL
and	NULL
the	NULL
capacity	NULL
to	NULL
grow	NULL
independently	NULL
of	NULL
IL-2	NULL
.	NULL

The	NULL
culture	NULL
conditions	NULL
used	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
IL-2	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
23	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Human	NULL
recombinant	NULL
interleukins	NULL
were	NULL
gifts	NULL
of	NULL
GLAXO	NULL
IMB	NULL
S.A.	NULL
(	NULL
Plan-les-Ouates	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

IL-16	NULL
(	NULL
IL-1	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
ng/ml	NULL
;	NULL
IL-2	NULL
was	NULL
used	NULL
at	NULL
100	NULL
units/ml	NULL
.	NULL

Dithiocarbamate	NULL
(	NULL
Sigma	NULL
,	NULL
Buchs	NULL
,	NULL
Switzerland	NULL
)	NULL
compounds	NULL
were	NULL
used	NULL
at	NULL
final	NULL
concentrations	NULL
of	NULL
10	NULL
and	NULL
100	NULL
pm	NULL
.	NULL

RNA	NULL
and	NULL
Nuclear	NULL
Extract	NULL
Preparations	NULL
:	NULL
RNase	NULL
Protection	NULL
and	NULL
Band	NULL
Shift	NULL
Assays-RNA	NULL
was	NULL
extracted	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Gough	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
same	NULL
method	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Methods	NULL
used	NULL
for	NULL
RNase	NULL
protection	NULL
and	NULL
band	NULL
shift	NULL
assays	NULL
are	NULL
modifications	NULL
of	NULL
techniques	NULL
developed	NULL
by	NULL
others	NULL
and	NULL
have	NULL
been	NULL
described	NULL
in	NULL
previous	NULL
publications	NULL
(	NULL
23	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
have	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
mouse	NULL
IL-2Ra	NULL
probe	NULL
corresponds	NULL
to	NULL
a	NULL
PstI	NULL
cDNA	NULL
segment	NULL
(	NULL
bp	NULL
89-503	NULL
)	NULL
.	NULL

Experiments	NULL
with	NULL
rat	NULL
T	NULL
cell	NULL
blast	NULL
RNA	NULL
showed	NULL
that	NULL
this	NULL
probe	NULL
also	NULL
protects	NULL
defined	NULL
fragments	NULL
of	NULL
rat	NULL
IL-2Ra	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RNase	NULL
protection	NULL
reactions	NULL
were	NULL
fractionated	NULL
on	NULL
sequencing	NULL
gels	NULL
.	NULL

Signals	NULL
were	NULL
quantified	NULL
with	NULL
a	NULL
PhosphorImager	NULL
,	NULL
model	NULL
SF	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
CA	NULL
94086	NULL
)	NULL
.	NULL

IL-2Ra	NULL
signals	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
B-actin	NULL
signal	NULL
,	NULL
which	NULL
was	NULL
reduced	NULL
to	NULL
comparable	NULL
levels	NULL
by	NULL
labeling	NULL
the	NULL
B-actin	NULL
probe	NULL
with	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
JCTP	NULL
of	NULL
10-fold	NULL
lower	NULL
specific	NULL
activity	NULL
.	NULL

Sequence	NULL
Analysis-Parts	NULL
of	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
5'-FR	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
have	NULL
been	NULL
published	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
from	NULL
bp	NULL
-2589	NULL
to	NULL
+93	NULL
has	NULL
been	NULL
determined	NULL
on	NULL
both	NULL
strands	NULL
by	NULL
the	NULL
dideoxy	NULL
method	NULL
and	NULL
entered	NULL
into	NULL
the	NULL
Genebank/EMBL	NULL
data	NULL
bases	NULL
as	NULL
modification	NULL
of	NULL
the	NULL
original	NULL
sequence	NULL
(	NULL
EMBL	NULL
accession	NULL
M16398	NULL
,	NULL
version	NULL
10	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
5'-flanking	NULL
sequences	NULL
were	NULL
aligned	NULL
with	NULL
the	NULL
program	NULL
BestFit	NULL
from	NULL
the	NULL
GCG	NULL
sequence	NULL
analysis	NULL
software	NULL
package	NULL
(	NULL
30	NULL
)	NULL
using	NULL
the	NULL
default	NULL
scoring	NULL
system	NULL
(	NULL
match	NULL
=	NULL
1.0	NULL
,	NULL
mismatch	NULL
=	NULL
-0.9	NULL
,	NULL
gap	NULL
weight	NULL
=	NULL
5.0	NULL
+	NULL
0.3	NULL
x	NULL
gap	NULL
length	NULL
)	NULL
.	NULL

TATA	NULL
box	NULL
(	NULL
31	NULL
)	NULL
and	NULL
GC	NULL
box	NULL
(	NULL
81	NULL
)	NULL
motifs	NULL
were	NULL
identified	NULL
using	NULL
program	NULL
EukProm	NULL
from	NULL
PC/Gene	NULL
(	NULL
release	NULL
6.7	NULL
(	NULL
1992	NULL
)	NULL
,	NULL
IntelliGeneties	NULL
Inc.	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Consensus	NULL
recognition	NULL
sequences	NULL
for	NULL
transcription	NULL
factors	NULL
were	NULL
located	NULL
with	NULL
the	NULL
GCG	NULL
program	NULL
FindPattern	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Searches	NULL
for	NULL
local	NULL
sequence	NULL
similarities	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
BLAST	NULL
server	NULL
at	NULL
the	NULL
National	NULL
Institute	NULL
for	NULL
Biotechnology	NULL
Information	NULL
in	NULL
Bethesda	NULL
,	NULL
MD	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Optimal	NULL
local	NULL
alignments	NULL
between	NULL
selected	NULL
sequence	NULL
regions	NULL
were	NULL
generated	NULL
with	NULL
the	NULL
aid	NULL
of	NULL
GCG	NULL
program	NULL
BestFit	NULL
(	NULL
30	NULL
)	NULL
using	NULL
the	NULL
default	NULL
scoring	NULL
system	NULL
(	NULL
match	NULL
=	NULL
1.0	NULL
,	NULL
mismatch	NULL
=	NULL
-0.9	NULL
,	NULL
gap	NULL
weight	NULL
=	NULL
5.0	NULL
+	NULL
0.3	NULL
x	NULL
gap	NULL
length	NULL
)	NULL
.	NULL

Statistical	NULL
significance	NULL
of	NULL
optimal	NULL
alignment	NULL
scores	NULL
was	NULL
assessed	NULL
by	NULL
calculating	NULL
Z	NULL
scores	NULL
based	NULL
on	NULL
100	NULL
shuffled	NULL
sequence	NULL
pairs	NULL
.	NULL

Type	NULL
and	NULL
orientation	NULL
of	NULL
repetitive	NULL
elements	NULL
in	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
5'-FR	NULL
were	NULL
identified	NULL
by	NULL
computing	NULL
optimal	NULL
alignment	NULL
scores	NULL
against	NULL
a	NULL
representative	NULL
set	NULL
of	NULL
mammalian	NULL
LINE	NULL
and	NULL
SINE	NULL
sequences	NULL
,	NULL
including	NULL
the	NULL
sequences	NULL
with	NULL
the	NULL
following	NULL
EMBL	NULL
accession	NULL
numbers	NULL
:	NULL
X52235	NULL
(	NULL
version	NULL
10	NULL
)	NULL
,	NULL
M30839	NULL
(	NULL
version	NULL
1	NULL
)	NULL
,	NULL
M30839	NULL
(	NULL
version	NULL
4	NULL
)	NULL
,	NULL
JO0628	NULL
(	NULL
version	NULL
1	NULL
,	NULL
position	NULL
93-222	NULL
)	NULL
,	NULL
MS87890	NULL
(	NULL
version	NULL
2	NULL
)	NULL
,	NULL
K02592	NULL
(	NULL
version	NULL
2	NULL
,	NULL
position	NULL
250-660	NULL
)	NULL
,	NULL
JO1879	NULL
(	NULL
version	NULL
1	NULL
,	NULL
position	NULL
441-522	NULL
)	NULL
,	NULL
X02215	NULL
(	NULL
version	NULL
3	NULL
,	NULL
position	NULL
587-849	NULL
)	NULL
.	NULL

The	NULL
number	NULL
and	NULL
approximate	NULL
location	NULL
of	NULL
elements	NULL
sharing	NULL
significant	NULL
sequence	NULL
similarities	NULL
with	NULL
one	NULL
of	NULL
the	NULL
promoter	NULL
regions	NULL
was	NULL
determined	NULL
by	NULL
matrix	NULL
comparisons	NULL
using	NULL
GCG	NULL
programs	NULL
Compare	NULL
and	NULL
DotPlot	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
delineation	NULL
of	NULL
the	NULL
repetitive	NULL
regions	NULL
as	NULL
shown	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
is	NULL
based	NULL
on	NULL
optimal	NULL
local	NULL
sequence	NULL
alignments	NULL
between	NULL
the	NULL
regions	NULL
highlighted	NULL
by	NULL
the	NULL
DotPlot	NULL
method	NULL
and	NULL
the	NULL
corresponding	NULL
repetitive	NULL
element	NULL
sequence	NULL
.	NULL

Internal	NULL
direct	NULL
repeats	NULL
were	NULL
searched	NULL
for	NULL
by	NULL
the	NULL
DotPlot	NULL
method	NULL
and	NULL
by	NULL
generating	NULL
multiple	NULL
locally	NULL
optimal	NULL
sequence	NULL
alignments	NULL
with	NULL
the	NULL
aid	NULL
of	NULL
program	NULL
LAlign	NULL
from	NULL
the	NULL
FastA	NULL
package	NULL
(	NULL
83	NULL
)	NULL
.	NULL

The	NULL
scoring	NULL
system	NULL
for	NULL
multiple	NULL
local	NULL
sequence	NULL
alignment	NULL
was	NULL
as	NULL
follows	NULL
:	NULL
match	NULL
=	NULL
4	NULL
,	NULL
mismatch	NULL
=	NULL
-3	NULL
,	NULL
gap	NULL
weight	NULL
=	NULL
8	NULL
+	NULL
4	NULL
X	NULL
gap	NULL
length	NULL
.	NULL

Statistical	NULL
significance	NULL
of	NULL
direct	NULL
repeats	NULL
was	NULL
assessed	NULL
by	NULL
Z	NULL
score	NULL
calculations	NULL
using	NULL
program	NULL
RSS	NULL
from	NULL
the	NULL
same	NULL
package	NULL
.	NULL

Plasmids-Plasmids	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Ref	NULL
.	NULL

23	NULL
.	NULL

Unless	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
mentioned	NULL
otherwise	NULL
,	NULL
plasmid	NULL
constructions	NULL
were	NULL
made	NULL
in	NULL
pGEM3Zf	NULL
(	NULL
+	NULL
)	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
reference	NULL
plasmid	NULL
pGBAcBGID	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
ref	NULL
)	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
plasmid	NULL
pwt18GI	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
pwt	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
the	NULL
SphI-Pstl	NULL
fragment	NULL
from	NULL
pUC18	NULL
mIL-2Rp	NULL
(	NULL
29	NULL
)	NULL
was	NULL
joined	NULL
to	NULL
the	NULL
1664-bp	NULL
PvuII	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
fragment	NULL
from	NULL
Z-pCRUpRChrBG-1	NULL
(	NULL
35	NULL
)	NULL
.	NULL

To	NULL
facilitate	NULL
the	NULL
introduction	NULL
of	NULL
deletions	NULL
in	NULL
segment	NULL
B	NULL
and	NULL
C	NULL
,	NULL
we	NULL
constructed	NULL
plasmid	NULL
pBC	NULL
in	NULL
which	NULL
B	NULL
and	NULL
C	NULL
,	NULL
separated	NULL
by	NULL
a	NULL
Psfl	NULL
site	NULL
,	NULL
are	NULL
cloned	NULL
between	NULL
the	NULL
Xbal	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pGEM3Zf	NULL
(	NULL
+	NULL
)	NULL
.	NULL

In	NULL
plasmids	NULL
pABC1BG1	NULL
(	NULL
pABC	NULL
)	NULL
and	NULL
pABC2GGI	NULL
,	NULL
(	NULL
pABC2	NULL
)	NULL
segments	NULL
B	NULL
and	NULL
C	NULL
are	NULL
replaced	NULL
by	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
5'-gatcAAGCTTaagTCTA	NULL
3	NULL
'	NULL
,	NULL
3°	NULL
TTCGAAt-tcAGATCTag	NULL
5	NULL
)	NULL
containing	NULL
two	NULL
unique	NULL
restriction	NULL
sites	NULL
,	NULL
HindIII	NULL
(	NULL
bold-face	NULL
)	NULL
and	NULL
Xbal	NULL
{	NULL
underlined	NULL
)	NULL
,	NULL
in	NULL
either	NULL
one	NULL
or	NULL
the	NULL
other	NULL
orientation	NULL
.	NULL

pR1GGI	NULL
(	NULL
pR	NULL
)	NULL
and	NULL
pRiGGI	NULL
(	NULL
pRi	NULL
)	NULL
were	NULL
obtained	NULL
by	NULL
introducing	NULL
the	NULL
Xbal-HindIII	NULL
fragment	NULL
of	NULL
pBC	NULL
into	NULL
pABC	NULL
or	NULL
pABC2	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
checked	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Mutations	NULL
in	NULL
Segment	NULL
C-Deletions	NULL
ACI-AC5	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
were	NULL
introduced	NULL
into	NULL
pBC	NULL
using	NULL
existing	NULL
restriction	NULL
sites	NULL
.	NULL

The	NULL
modified	NULL
Xbal-HindIII	NULL
fragments	NULL
were	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
Xbal-HindIII	NULL
fragment	NULL
in	NULL
pR	NULL
.	NULL

Deletions	NULL
and	NULL
substitution	NULL
mutations	NULL
within	NULL
segment	NULL
C3	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
were	NULL
introduced	NULL
into	NULL
pBC	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
system	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

36	NULL
.	NULL

The	NULL
modified	NULL
Nsil	NULL
fragments	NULL
were	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
corresponding	NULL
fragment	NULL
of	NULL
pwt	NULL
.	NULL

Deletions	NULL
in	NULL
Segment	NULL
D-To	NULL
construct	NULL
deletions	NULL
in	NULL
region	NULL
D	NULL
of	NULL
pwt	NULL
,	NULL
this	NULL
segment	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
Bg/II	NULL
(	NULL
-802	NULL
)	NULL
to	NULL
Psfl	NULL
(	NULL
+93	NULL
)	NULL
fragment	NULL
.	NULL

Segments	NULL
D1-D6	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
were	NULL
removed	NULL
using	NULL
suitable	NULL
restriction	NULL
sites	NULL
.	NULL

The	NULL
modified	NULL
D	NULL
segments	NULL
were	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
Xbal-Bsm1I	NULL
fragment	NULL
of	NULL
plasmid	NULL
pR	NULL
,	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
plasmids	NULL
pRAD1I-pRADS	NULL
.	NULL

From	NULL
each	NULL
of	NULL
these	NULL
plasmids	NULL
,	NULL
segment	NULL
C	NULL
was	NULL
removed	NULL
by	NULL
digestion	NULL
with	NULL
Psfl	NULL
and	NULL
Xbal	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
pRACAD1	NULL
,	NULL
etc	NULL
.	NULL

(	NULL
see	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

pG1	NULL
Recombinants-pG1.BC	NULL
was	NULL
obtained	NULL
by	NULL
subcloning	NULL
the	NULL
Xbal-HindIII	NULL
fragment	NULL
of	NULL
pBC	NULL
into	NULL
pG1	NULL
(	NULL
37	NULL
)	NULL
,	NULL
The	NULL
resulting	NULL
plasmid	NULL
contains	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
segment	NULL
B+C	NULL
of	NULL
the	NULL
IL-2Ra	NULL
5'-flanking	NULL
region	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
.	NULL

To	NULL
introduce	NULL
fragments	NULL
C3	NULL
or	NULL
C2+C3	NULL
into	NULL
pG1	NULL
,	NULL
these	NULL
segments	NULL
were	NULL
amplified	NULL
from	NULL
pwt	NULL
with	NULL
the	NULL
proofreading	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
contained	NULL
an	NULL
Xbal	NULL
site	NULL
at	NULL
the	NULL
5	NULL
and	NULL
a	NULL
HindIII	NULL
site	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
these	NULL
enzymes	NULL
and	NULL
ligated	NULL
with	NULL
HindIII-Xbal-digested	NULL
pG1l	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
contain	NULL
single	NULL
copies	NULL
of	NULL
segment	NULL
-	NULL
1635	NULL
to	NULL
-1301	NULL
(	NULL
pG1.C2+C3	NULL
)	NULL
or	NULL
segment	NULL
-1403	NULL
to	NULL
-1301	NULL
(	NULL
pG1.C3	NULL
)	NULL
of	NULL
the	NULL
IL-2Ra	NULL
5'-flanking	NULL
region	NULL
in	NULL
their	NULL
normal	NULL
orientation	NULL
.	NULL

Reporter	NULL
Gene	NULL
Assay-Cells	NULL
were	NULL
transiently	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
according	NULL
to	NULL
Ref	NULL
.	NULL

38	NULL
.	NULL

Reporter	NULL
gene	NULL
expression	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
defined	NULL
ratio	NULL
of	NULL
an	NULL
IL-2Ro/rabbit	NULL
-globin	NULL
gene	NULL
construct	NULL
and	NULL
the	NULL
reference	NULL
plasmid	NULL
.	NULL

This	NULL
contains	NULL
a	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
with	NULL
a	NULL
40-bp	NULL
deletion	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
and	NULL
is	NULL
transcribed	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
constitutive	NULL
chicken	NULL
B-actin	NULL
promoter	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
was	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
.	NULL

After	NULL
cDNA	NULL
synthesis	NULL
from	NULL
a	NULL
poly	NULL
(	NULL
dT	NULL
)	NULL
primer	NULL
with	NULL
avian	NULL
myoblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
,	NULL
B-globin	NULL
cDNA	NULL
was	NULL
amplified	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-*	NULL
``	NULL
PIldATP	NULL
with	NULL
primers	NULL
spanning	NULL
the	NULL
deletion	NULL
in	NULL
the	NULL
reference	NULL
plasmid	NULL
and	NULL
the	NULL
first	NULL
intron	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
we	NULL
used	NULL
,	NULL
instead	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
3	NULL
'	NULL
primer	NULL
(	NULL
34	NULL
)	NULL
,	NULL
the	NULL
oligonucleotide	NULL
5°	NULL
ACGTTGCCCAG-GAG	NULL
L	NULL
GAAGT	NULL
3	NULL
'	NULL
,	NULL
which	NULL
spans	NULL
the	NULL
second	NULL
intron	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
(	NULL
L	NULL
marks	NULL
exon	NULL
boundaries	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
this	NULL
reduces	NULL
signals	NULL
due	NULL
to	NULL
resid-val	NULL
plasmid	NULL
contaminating	NULL
mRNA	NULL
preparations	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
denatured	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
sequencing	NULL
gel	NULL
.	NULL

mRNA	NULL
derived	NULL
signals	NULL
were	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
.	NULL

RESULTS	NULL
Induction	NULL
of	NULL
IL-2Ra	NULL
Expression	NULL
in	NULL
PC6GO	NULL
Occurs	NULL
in	NULL
Two	NULL
Phases-PC6O	NULL
is	NULL
a	NULL
somatic	NULL
cell	NULL
hybrid	NULL
between	NULL
the	NULL
mouse	NULL
cytolytic	NULL
T	NULL
lymphocyte	NULL
line	NULL
B6.1	NULL
and	NULL
the	NULL
rat	NULL
thymic	NULL
lymphoma	NULL
C58	NULL
(	NULL
21	NULL
)	NULL
.	NULL

It	NULL
has	NULL
inherited	NULL
from	NULL
its	NULL
lymphoma	NULL
parent	NULL
the	NULL
CD4~CD8~	NULL
phenotype	NULL
(	NULL
22	NULL
)	NULL
and	NULL
the	NULL
capacity	NULL
to	NULL
grow	NULL
independently	NULL
of	NULL
IL-2	NULL
.	NULL

In	NULL
unstimulated	NULL
PCBO	NULL
cells	NULL
,	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
is	NULL
barely	NULL
detectable	NULL
.	NULL

IL-1	NULL
and	NULL
IL-2	NULL
induce	NULL
appearance	NULL
of	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
and	NULL
synergize	NULL
to	NULL
control	NULL
its	NULL
level	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
interleukin	NULL
response	NULL
pattern	NULL
of	NULL
the	NULL
rat	NULL
IL-2Ra	NULL
gene	NULL
in	NULL
the	NULL
parental	NULL
C58	NULL
lymphoma	NULL
and	NULL
in	NULL
PC6O	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
mouse	NULL
gene	NULL
in	NULL
PC6O	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
excludes	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
interleukin	NULL
response	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
is	NULL
an	NULL
artifact	NULL
due	NULL
to	NULL
a	NULL
rearrangement	NULL
of	NULL
the	NULL
mouse	NULL
gene	NULL
in	NULL
the	NULL
parental	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
10745	NULL
A	NULL
Stimuli	NULL
:	NULL
f	NULL
--	NULL
-	NULL
IL-1	NULL
4	NULL
IL-2	NULL
.	NULL

1	NULL
U	NULL
[	NULL
h	NULL
]	NULL
:	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
508	NULL
10	NULL
18	NULL
26	NULL
/	NULL
Probes	NULL
:	NULL
m	NULL
Protected	NULL
o	NULL
fragments	NULL
:	NULL
IL-2Ra	NULL
E	NULL
»	NULL
Tas	NULL
g	NULL
0.1	NULL
-g	NULL
IL-2R	NULL
id	NULL
e	NULL
CC	NULL
I	NULL
’	NULL
-o	NULL
E	NULL
4g	NULL
5	NULL
5	NULL
f	NULL
<	NULL
8	NULL
F	NULL
z	NULL
E	NULL
0.01	NULL
-	NULL
/	NULL
CC	NULL
iz	NULL
E	NULL
o	NULL
m	NULL
2	NULL
o	NULL
e	NULL
B-actin	NULL
_	NULL
I-	NULL
=	NULL
'	NULL
m	NULL
x	NULL
m	NULL
fe	NULL
}	NULL
c	NULL
0.001	NULL
-/	NULL
-l	NULL
(	NULL
-actin	NULL
m	NULL
0.0001	NULL
|	NULL
T	NULL
|	NULL
|	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
30	NULL
Hours	NULL
of	NULL
induction	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Kinetics	NULL
of	NULL
IL-1	NULL
+	NULL
IL-2-induced	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
increase	NULL
in	NULL
PC6O0	NULL
.	NULL

A	NULL
,	NULL
PC6O	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
saturating	NULL
concentrations	NULL
of	NULL
IL-1	NULL
and	NULL
IL-2	NULL
.	NULL

Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
assayed	NULL
by	NULL
RNase	NULL
protection	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
antisense	NULL
RNA	NULL
probes	NULL
for	NULL
mouse	NULL
IL-2Ra	NULL
and	NULL
B-actin	NULL
(	NULL
empty	NULL
arrowheads	NULL
on	NULL
left	NULL
side	NULL
of	NULL
gel	NULL
,	NULL
see	NULL
``	NULL
Material	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
B-actin	NULL
probe	NULL
is	NULL
10	NULL
times	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
signals	NULL
were	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
and	NULL
normalized	NULL
to	NULL
the	NULL
mouse	NULL
B-actin	NULL
signal	NULL
in	NULL
the	NULL
same	NULL
lane	NULL
.	NULL

mouse	NULL
T	NULL
cell	NULL
line	NULL
or	NULL
in	NULL
PC6O	NULL
itself	NULL
.	NULL

A	NULL
very	NULL
similar	NULL
response	NULL
is	NULL
observed	NULL
in	NULL
normal	NULL
CD4~CD8~	NULL
thymocytes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Previously	NULL
reported	NULL
run-on	NULL
experiments	NULL
showed	NULL
that	NULL
IL-1	NULL
and	NULL
IL-2	NULL
regulate	NULL
IL-2Ra	NULL
gene	NULL
expression	NULL
in	NULL
PC6O	NULL
cells	NULL
by	NULL
changing	NULL
its	NULL
rate	NULL
of	NULL
transcription	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
(	NULL
65	NULL
)	NULL
that	NULL
the	NULL
same	NULL
is	NULL
true	NULL
for	NULL
normal	NULL
thymocytes	NULL
.	NULL

Detailed	NULL
analysis	NULL
by	NULL
RNase	NULL
protection	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
reveals	NULL
that	NULL
the	NULL
interleukin-induced	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
levels	NULL
in	NULL
PC6O	NULL
cells	NULL
is	NULL
biphasic	NULL
.	NULL

Stimulation	NULL
with	NULL
IL-1	NULL
+	NULL
IL-2	NULL
induces	NULL
detectable	NULL
transcripts	NULL
within	NULL
1	NULL
h.	NULL
The	NULL
rate	NULL
of	NULL
increase	NULL
in	NULL
transcript	NULL
levels	NULL
slows	NULL
down	NULL
between	NULL
4	NULL
and	NULL
5	NULL
h	NULL
after	NULL
interleukin	NULL
addition	NULL
,	NULL
but	NULL
accelerates	NULL
again	NULL
between	NULL
10	NULL
and	NULL
18	NULL
h.	NULL
This	NULL
biphasic	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
mRNA	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
three	NULL
other	NULL
experiments	NULL
.	NULL

Maximal	NULL
transcript	NULL
levels	NULL
,	NULL
more	NULL
than	NULL
1000-fold	NULL
above	NULL
background	NULL
,	NULL
are	NULL
reached	NULL
by	NULL
about	NULL
48	NULL
h	NULL
(	NULL
Ref	NULL
.	NULL

11	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Initial	NULL
,	NULL
IL-1-induced	NULL
Phase	NULL
of	NULL
IL-2Ra	NULL
«	NULL
Induction	NULL
Can	NULL
Be	NULL
Blocked	NULL
by	NULL
Inhibitors	NULL
of	NULL
NF-kB	NULL
Activation-We	NULL
previously	NULL
showed	NULL
that	NULL
the	NULL
early	NULL
response	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
IL-1	NULL
alone	NULL
and	NULL
is	NULL
protein	NULL
synthesis-independent	NULL
(	NULL
11	NULL
)	NULL
.	NULL

IL-2	NULL
has	NULL
no	NULL
or	NULL
very	NULL
little	NULL
effect	NULL
during	NULL
this	NULL
stage	NULL
.	NULL

The	NULL
immediate	NULL
responses	NULL
of	NULL
many	NULL
genes	NULL
to	NULL
IL-1	NULL
are	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
PC6O	NULL
cells	NULL
,	NULL
IL-1	NULL
induces	NULL
appearance	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
activates	NULL
transcription	NULL
from	NULL
promoters	NULL
with	NULL
NF-kB	NULL
binding	NULL
sites	NULL
(	NULL
23	NULL
,	NULL
41	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
whether	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
42	NULL
)	NULL
block	NULL
the	NULL
early	NULL
response	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
to	NULL
IL-1	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
100	NULL
unt	NULL
pyrrolidinedithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
prior	NULL
to	NULL
and	NULL
during	NULL
a	NULL
3-h	NULL
stimulation	NULL
with	NULL
IL-1	NULL
inhibits	NULL
appearance	NULL
of	NULL
NF-kB	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
completely	NULL
blocks	NULL
the	NULL
rise	NULL
in	NULL
IL-2Ra	NULL
mRNA	NULL
.	NULL

10	NULL
um	NULL
PDTC	NULL
has	NULL
no	NULL
inhibitory	NULL
effect	NULL
.	NULL

Longer	NULL
incubation	NULL
at	NULL
inhibitory	NULL
doses	NULL
results	NULL
in	NULL
significant	NULL
loss	NULL
of	NULL
viability	NULL
.	NULL

Diethyl-DTC	NULL
has	NULL
the	NULL
same	NULL
effects	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
similar	NULL
sensitivity	NULL
of	NULL
NF-kB	NULL
activation	NULL
and	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
appearance	NULL
to	NULL
PDTC	NULL
suggests	NULL
that	NULL
the	NULL
two	NULL
phenomena	NULL
are	NULL
linked	NULL
and	NULL
that	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
induction	NULL
by	NULL
IL-1	NULL
is	NULL
mediated	NULL
by	NULL
NF-kB	NULL
.	NULL

IL-1	NULL
Primes	NULL
PC6O	NULL
Cells	NULL
to	NULL
Become	NULL
IL-2	NULL
Responsive-Stimu-lation	NULL
of	NULL
PC6O	NULL
with	NULL
IL-1	NULL
alone	NULL
induces	NULL
,	NULL
beyond	NULL
the	NULL
first	NULL
protein	NULL
synthesis-independent	NULL
phase	NULL
of	NULL
the	NULL
response	NULL
,	NULL
a	NULL
significant	NULL
further	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
(	NULL
11	NULL
)	NULL
.	NULL

This	NULL
is	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
IL-1	NULL
induces	NULL
PC6O	NULL
cells	NULL
to	NULL
secrete	NULL
IL-2	NULL
,	NULL
so	NULL
that	NULL
treatment	NULL
with	NULL
IL-1	NULL
alone	NULL
amounts	NULL
to	NULL
stimulation	NULL
with	NULL
both	NULL
interleukins	NULL
.	NULL

IL-2	NULL
secretion	NULL
peaks	NULL
around	NULL
24	NULL
h	NULL
,	NULL
and	NULL
after	NULL
72	NULL
h	NULL
IL-2	NULL
is	NULL
no	NULL
longer	NULL
detectable	NULL
in	NULL
culture	NULL
supernatants	NULL
.	NULL

This	NULL
explains	NULL
why	NULL
IL-2Ra	NULL
mRNA	NULL
levels	NULL
remain	NULL
maximal	NULL
in	NULL
cells	NULL
stimulated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
both	NULL
IL-1	NULL
and	NULL
exogenously	NULL
supplied	NULL
IL-2	NULL
(	NULL
11	NULL
)	NULL
,	NULL
while	NULL
they	NULL
have	NULL
returned	NULL
to	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
only	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
IL-2	NULL
to	NULL
such	NULL
IL-1-prestimulated	NULL
cells	NULL
induces	NULL
a	NULL
rapid	NULL
rise	NULL
in	NULL
IL-2Ra	NULL
mRNA	NULL
levels	NULL
,	NULL
whereas	NULL
in	NULL
cells	NULL
that	NULL
have	NULL
not	NULL
been	NULL
exposed	NULL
to	NULL
IL-1	NULL
,	NULL
IL-2	NULL
induces	NULL
a	NULL
barely	NULL
detectable	NULL
increase	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
initial	NULL
kinetics	NULL
of	NULL
the	NULL
response	NULL
of	NULL
cells	NULL
precultured	NULL
in	NULL
IL-1	NULL
do	NULL
not	NULL
depend	NULL
on	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
IL-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
preculture	NULL
in	NULL
IL-1	NULL
increases	NULL
the	NULL
capacity	NULL
of	NULL
PC6O	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
.	NULL

We	NULL
refer	NULL
to	NULL
this	NULL
effect	NULL
as	NULL
IL-1	NULL
priming	NULL
.	NULL

Priming	NULL
of	NULL
PC6O	NULL
cells	NULL
presumably	NULL
depends	NULL
on	NULL
a	NULL
low	NULL
level	NULL
of	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
that	NULL
persists	NULL
after	NULL
72	NULL
h	NULL
in	NULL
IL-1	NULL
,	NULL
necessary	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
IL-2	NULL
response	NULL
of	NULL
primed	NULL
PC6O	NULL
(	NULL
G3	NULL
)	NULL
cells	NULL
,	NULL
which	NULL
constitutively	NULL
express	NULL
a	NULL
human	NULL
IL-2Ra	NULL
«	NULL
cDNA	NULL
clone	NULL
(	NULL
24	NULL
)	NULL
,	NULL
is	NULL
much	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
PC6O	NULL
itself	NULL
.	NULL

But	NULL
the	NULL
fact	NULL
that	NULL
priming	NULL
can	NULL
be	NULL
observed	NULL
also	NULL
in	NULL
PC6O	NULL
(	NULL
G3	NULL
)	NULL
indicates	NULL
that	NULL
it	NULL
requires	NULL
other	NULL
IL-1l-induced	NULL
changes	NULL
.	NULL

PC6O	NULL
cells	NULL
express	NULL
the	NULL
IL-2RB	NULL
gene	NULL
constitutively	NULL
but	NULL
prolonged	NULL
exposure	NULL
to	NULL
IL-1	NULL
induces	NULL
a	NULL
10-30-fold	NULL
increase	NULL
in	NULL
IL-2RB	NULL
mRNA	NULL
and	NULL
a	NULL
10-fold	NULL
10746	NULL
A	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
B	NULL
PDTC	NULL
[	NULL
uM	NULL
]	NULL
:	NULL
NF-kB	NULL
activation	NULL
on	NULL
the	NULL
early	NULL
re	NULL
100	NULL
|	NULL
10	NULL
sponse	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
to	NULL
IL-1	NULL
.	NULL

IL-1	NULL
[	NULL
h	NULL
]	NULL
:	NULL
0	NULL
[	NULL
0	NULL
[	NULL
1121315	NULL
013	NULL
]	NULL
013	NULL
PDTC	NULL
[	NULL
uM	NULL
}	NULL
]	NULL
:	NULL
|	NULL
0	NULL
|100	NULL
PC6O0	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
Probes	NULL
:	NULL
Protected	NULL
IL-1	NULL
:	NULL
|	NULL
=	NULL
_+	NULL
{	NULL
-	NULL
+	NULL
IL-1	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
PDTC	NULL
.	NULL

The	NULL
inhibitor	NULL
was	NULL
added	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
IL-1	NULL
.	NULL

Three	NULL
h	NULL
after	NULL
IL-1	NULL
addition	NULL
,	NULL
cytoplasmic	NULL
RNA	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

A	NULL
,	NULL
IL-2Ra	NULL
«	NULL
and	NULL
fB-actin	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

Empty	NULL
arrow	NULL
IL-2Ro	NULL
.	NULL

t	NULL
fragments	NULL
:	NULL
-at	NULL
IL-2Ra	NULL
NF-KB	NULL
>	NULL
x¥~tga	NULL
heads	NULL
on	NULL
the	NULL
left	NULL
,	NULL
undigested	NULL
probes	NULL
;	NULL
filled	NULL
arrowheads	NULL
on	NULL
the	NULL
right	NULL
,	NULL
mRNA	NULL
signals	NULL
.	NULL

The	NULL
signals	NULL
just	NULL
below	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
IL-2Ra	NULL
probe	NULL
are	NULL
due	NULL
to	NULL
a	NULL
interferon-y	NULL
probe	NULL
also	NULL
present	NULL
in	NULL
the	NULL
re-action	NULL
.	NULL

B	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
detected	NULL
by	NULL
band	NULL
shift	NULL
assay	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TC-II	NULL
element	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
protein	NULL
giving	NULL
rise	NULL
to	NULL
the	NULL
complex	NULL
labeled	NULL
as	NULL
NF-kB	NULL
has	NULL
been	NULL
verified	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

B-Actin	NULL
&	NULL
1	NULL
increase	NULL
in	NULL
high	NULL
affinity	NULL
IL-2	NULL
receptors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
priming	NULL
also	NULL
depends	NULL
on	NULL
increased	NULL
IL-2R	NULL
$	NULL
chain	NULL
expression	NULL
.	NULL

There	NULL
may	NULL
yet	NULL
be	NULL
other	NULL
factors	NULL
that	NULL
control	NULL
responsiveness	NULL
.	NULL

This	NULL
might	NULL
explain	NULL
the	NULL
considerable	NULL
variation	NULL
in	NULL
the	NULL
maximal	NULL
inducible	NULL
level	NULL
of	NULL
IL-2Ra	NULL
mRNA	NULL
in	NULL
primed	NULL
PC6O	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
3-10	NULL
times	NULL
weaker	NULL
than	NULL
that	NULL
in	NULL
unprimed	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
+	NULL
IL-2	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-1	NULL
has	NULL
two	NULL
effects	NULL
on	NULL
PC6O	NULL
cells	NULL
.	NULL

First	NULL
,	NULL
it	NULL
rapidly	NULL
induces	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
via	NULL
protein	NULL
synthesis-independent	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Second	NULL
,	NULL
it	NULL
increases	NULL
the	NULL
capacity	NULL
of	NULL
PC6O	NULL
cells	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
,	NULL
partly	NULL
by	NULL
increasing	NULL
IL-2Ra	NULL
«	NULL
and	NULL
IL-2RB	NULL
expression	NULL
.	NULL

This	NULL
priming	NULL
effect	NULL
permitted	NULL
us	NULL
to	NULL
use	NULL
PC6O	NULL
cells	NULL
for	NULL
the	NULL
mapping	NULL
of	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
control	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

Mapping	NULL
of	NULL
Interleukin	NULL
Responsive	NULL
cis-	NULL
Acting	NULL
Elements	NULL
in	NULL
the	NULL
IL-2Ra	NULL
Gene-Previously	NULL
,	NULL
we	NULL
had	NULL
shown	NULL
that	NULL
in	NULL
PC6O	NULL
cells	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
comprising	NULL
the	NULL
promoter	NULL
,	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
and	NULL
a	NULL
2.5-kb	NULL
5'-FR	NULL
(	NULL
position	NULL
-2539	NULL
to	NULL
+93	NULL
,	NULL
segment	NULL
A-D	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
conferred	NULL
on	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
a	NULL
response	NULL
pattern	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
that	NULL
resembled	NULL
closely	NULL
that	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
CD4~CD8~	NULL
thymocytes	NULL
of	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
same	NULL
construct	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
expression	NULL
responds	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
with	NULL
the	NULL
same	NULL
pattern	NULL
as	NULL
in	NULL
PC6O	NULL
(	NULL
65	NULL
)	NULL
.	NULL

For	NULL
the	NULL
mapping	NULL
of	NULL
interleukin	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
,	NULL
we	NULL
switched	NULL
from	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
to	NULL
a	NULL
rabbit	NULL
B-globin	NULL
reporter	NULL
gene	NULL
in	NULL
order	NULL
to	NULL
be	NULL
able	NULL
to	NULL
measure	NULL
reporter	NULL
gene	NULL
mRNA	NULL
levels	NULL
with	NULL
a	NULL
previously	NULL
described	NULL
PCR-based	NULL
assay	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
method	NULL
allows	NULL
very	NULL
accurate	NULL
quantification	NULL
of	NULL
promoter	NULL
responses	NULL
to	NULL
stimulation	NULL
,	NULL
e.g	NULL
.	NULL

with	NULL
interleukins	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

4B	NULL
shows	NULL
that	NULL
the	NULL
interleukin	NULL
responses	NULL
of	NULL
plasmid	NULL
pR	NULL
,	NULL
which	NULL
contains	NULL
segments	NULL
A-D	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
5-FR	NULL
,	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
equivalent	NULL
chloramphenicol	NULL
acetyltransferase	NULL
construct	NULL
(	NULL
pmIL-2RaPrCAT1	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
.	NULL

When	NULL
plasmid	NULL
pR	NULL
is	NULL
transfected	NULL
into	NULL
unprimed	NULL
PC6O0	NULL
cells	NULL
,	NULL
subsequent	NULL
stimulation	NULL
with	NULL
IL-1	NULL
alone	NULL
induces	NULL
,	NULL
on	NULL
average	NULL
,	NULL
a	NULL
5-fold	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

As	NULL
pointed	NULL
out	NULL
above	NULL
,	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
stimulation	NULL
with	NULL
IL-1	NULL
results	NULL
in	NULL
transient	NULL
IL-2	NULL
secretion	NULL
.	NULL

IL-2	NULL
stimulates	NULL
a	NULL
small	NULL
but	NULL
reproducible	NULL
response	NULL
,	NULL
whereas	NULL
both	NULL
cytokines	NULL
together	NULL
stimulate	NULL
a	NULL
12-fold	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
mRNA	NULL
.	NULL

When	NULL
the	NULL
same	NULL
plasmid	NULL
is	NULL
transfected	NULL
into	NULL
PC6O	NULL
cells	NULL
that	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
me	NULL
-a	NULL
B-Actin	NULL
Pos	NULL
acs	NULL
ec	NULL
tn	NULL
ie	NULL
have	NULL
been	NULL
primed	NULL
by	NULL
culture	NULL
in	NULL
IL-1	NULL
for	NULL
72	NULL
h	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
interleukin	NULL
responsiveness	NULL
changes	NULL
.	NULL

IL-2	NULL
alone	NULL
induces	NULL
a	NULL
response	NULL
that	NULL
is	NULL
almost	NULL
as	NULL
strong	NULL
as	NULL
that	NULL
to	NULL
IL-1	NULL
+	NULL
IL-2	NULL
.	NULL

Comparison	NULL
of	NULL
these	NULL
results	NULL
with	NULL
the	NULL
interleukin	NULL
response	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
in	NULL
primed	NULL
and	NULL
unprimed	NULL
PC6O	NULL
cells	NULL
shows	NULL
a	NULL
strikingly	NULL
similar	NULL
pattern	NULL
,	NULL
although	NULL
the	NULL
responses	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
gene	NULL
are	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
constructs	NULL
.	NULL

Such	NULL
differences	NULL
are	NULL
observed	NULL
in	NULL
most	NULL
transient	NULL
transfection	NULL
studies	NULL
of	NULL
promoters	NULL
.	NULL

There	NULL
is	NULL
considerable	NULL
variability	NULL
in	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
IL-2	NULL
response	NULL
of	NULL
pwt	NULL
in	NULL
primed	NULL
cells	NULL
(	NULL
see	NULL
e.g	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
which	NULL
may	NULL
be	NULL
related	NULL
to	NULL
similar	NULL
variation	NULL
in	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
,	NULL
but	NULL
the	NULL
response	NULL
pattern	NULL
is	NULL
completely	NULL
reproducible	NULL
.	NULL

The	NULL
interleukin	NULL
inducibility	NULL
of	NULL
plasmid	NULL
pwt	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
does	NULL
not	NULL
differ	NULL
significantly	NULL
from	NULL
that	NULL
of	NULL
pR	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
insertion	NULL
of	NULL
restriction	NULL
sites	NULL
in	NULL
the	NULL
latter	NULL
construct	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
interleukin	NULL
responsiveness	NULL
.	NULL

Comparing	NULL
the	NULL
time	NULL
course	NULL
of	NULL
IL-2-induced	NULL
accumulation	NULL
of	NULL
IL-2Ra	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
with	NULL
that	NULL
of	NULL
plasmid	NULL
pwt	NULL
mRNA	NULL
in	NULL
unprimed	NULL
and	NULL
IL-1	NULL
primed	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
both	NULL
responded	NULL
without	NULL
a	NULL
measurable	NULL
lag	NULL
and	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
many	NULL
if	NULL
not	NULL
all	NULL
of	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
control	NULL
the	NULL
complex	NULL
response	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
are	NULL
contained	NULL
in	NULL
segments	NULL
A-D.	NULL
IL-2	NULL
Response	NULL
Elements-In	NULL
previous	NULL
experiments	NULL
,	NULL
we	NULL
had	NULL
found	NULL
that	NULL
segment	NULL
C	NULL
conferred	NULL
IL-2	NULL
responsiveness	NULL
on	NULL
a	NULL
heterologous	NULL
viral	NULL
(	NULL
HSV-tk	NULL
)	NULL
promoter	NULL
(	NULL
11	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
demonstrating	NULL
that	NULL
a	NULL
plasmid	NULL
in	NULL
which	NULL
segment	NULL
C	NULL
has	NULL
been	NULL
deleted	NULL
(	NULL
pRAC	NULL
)	NULL
can	NULL
still	NULL
respond	NULL
to	NULL
IL-1	NULL
in	NULL
unprimed	NULL
PC60	NULL
cells	NULL
but	NULL
completely	NULL
fails	NULL
to	NULL
respond	NULL
to	NULL
IL-2	NULL
in	NULL
either	NULL
primed	NULL
or	NULL
unprimed	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
deletion	NULL
of	NULL
segment	NULL
C	NULL
(	NULL
or	NULL
B+C	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
does	NULL
not	NULL
significantly	NULL
alter	NULL
constitutive	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
orientation	NULL
of	NULL
segment	NULL
C	NULL
in	NULL
the	NULL
5'-FR	NULL
can	NULL
be	NULL
inverted	NULL
(	NULL
in	NULL
plasmid	NULL
pRi	NULL
)	NULL
without	NULL
affecting	NULL
the	NULL
response	NULL
to	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

We	NULL
have	NULL
mapped	NULL
the	NULL
elements	NULL
in	NULL
segment	NULL
C	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
in	NULL
three	NULL
stages	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
first	NULL
step	NULL
,	NULL
we	NULL
introduced	NULL
a	NULL
series	NULL
of	NULL
contiguous	NULL
deletions	NULL
of	NULL
160-250	NULL
bp	NULL
into	NULL
segment	NULL
C.	NULL
Comparing	NULL
the	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
these	NULL
plasmids	NULL
in	NULL
IL-1-primed	NULL
PC60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
we	NULL
found	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
segment	NULL
between	NULL
bp	NULL
-1389	NULL
and	NULL
-1228	NULL
(	NULL
C3	NULL
)	NULL
completely	NULL
abolished	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

The	NULL
plasmid	NULL
with	NULL
this	NULL
deletion	NULL
(	NULL
pRAC3	NULL
)	NULL
failed	NULL
to	NULL
respond	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-2	NULL
for	NULL
times	NULL
between	NULL
1	NULL
and	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
segment	NULL
C2	NULL
,	NULL
immediately	NULL
upstream	NULL
of	NULL
C3	NULL
,	NULL
reproducibly	NULL
reduced	NULL
but	NULL
did	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
.02	NULL
e	NULL
not	NULL
primed	NULL
©	NULL
primed	NULL
.01	NULL
IL-2Ro	NULL
.	NULL

mRNA	NULL
level	NULL
(	NULL
normalized	NULL
to	NULL
B-actin	NULL
mRNA	NULL
)	NULL
0.0	NULL
ee-e-e	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Hours	NULL
of	NULL
induction	NULL
IL-2	NULL
[	NULL
h	NULL
]	NULL
:	NULL
0	NULL
1	NULL
3	NULL
5	NULL
8	NULL
10	NULL
24	NULL
36	NULL
48	NULL
Probe	NULL
:	NULL
Protected	NULL
IL-2Ro.m	NULL
)	NULL
fragments	NULL
:	NULL
wo	NULL
«	NULL
e	NULL
we	NULL
we	NULL
#	NULL
#	NULL
#	NULL
B	NULL
)	NULL
-a	NULL
|L-2R0	NULL
.	NULL

-a	NULL
B-actin	NULL
-o	NULL
W	NULL
Lane	NULL
:	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Priming	NULL
with	NULL
IL-1	NULL
increases	NULL
the	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
to	NULL
stimulation	NULL
with	NULL
IL-2	NULL
.	NULL

PC6O	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
in	NULL
normal	NULL
medium	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-1	NULL
.	NULL

Both	NULL
IL-1-primed	NULL
and	NULL
nonprimed	NULL
cells	NULL
were	NULL
aliquoted	NULL
into	NULL
fresh	NULL
cultures	NULL
(	NULL
0	NULL
h	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
later	NULL
.	NULL

During	NULL
this	NULL
time	NULL
,	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
individual	NULL
cultures	NULL
to	NULL
be	NULL
present	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
prior	NULL
to	NULL
RNA	NULL
extrac-tion	NULL
.	NULL

IL-2Ra	NULL
«	NULL
mRNA	NULL
was	NULL
detected	NULL
by	NULL
RNase	NULL
protection	NULL
.	NULL

Signals	NULL
were	NULL
quantified	NULL
and	NULL
normalized	NULL
to	NULL
B-actin	NULL
mRNA	NULL
signals	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
shown	NULL
in	NULL
B	NULL
shows	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
primed	NULL
cells	NULL
.	NULL

not	NULL
abolish	NULL
the	NULL
IL-2	NULL
response	NULL
.	NULL

Deletion	NULL
of	NULL
other	NULL
parts	NULL
of	NULL
segment	NULL
C	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
changes	NULL
in	NULL
IL-2	NULL
responsiveness	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
variations	NULL
in	NULL
constitutive	NULL
promoter	NULL
activity	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

To	NULL
delimit	NULL
more	NULL
precisely	NULL
the	NULL
sequences	NULL
within	NULL
segment	NULL
C3	NULL
that	NULL
were	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
,	NULL
we	NULL
introduced	NULL
six	NULL
contiguous	NULL
deletions	NULL
within	NULL
this	NULL
segment	NULL
into	NULL
plasmid	NULL
pwt	NULL
that	NULL
contains	NULL
the	NULL
entire	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
deletions	NULL
,	NULL
AC3.1	NULL
and	NULL
AC3.3	NULL
,	NULL
abolished	NULL
IL-2	NULL
responsiveness	NULL
,	NULL
and	NULL
removal	NULL
of	NULL
the	NULL
intervening	NULL
segment	NULL
,	NULL
C3.2	NULL
,	NULL
strongly	NULL
reduced	NULL
IL-2	NULL
responsiveness	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
whereas	NULL
deletions	NULL
in	NULL
the	NULL
remaining	NULL
part	NULL
of	NULL
segment	NULL
C3	NULL
(	NULL
AC3.4	NULL
,	NULL
AC3.5	NULL
and	NULL
AC3.6	NULL
)	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
corresponding	NULL
plasmids	NULL
to	NULL
be	NULL
stimulated	NULL
by	NULL
IL-2	NULL
.	NULL

Again	NULL
,	NULL
there	NULL
was	NULL
no	NULL
correlation	NULL
between	NULL
constitutive	NULL
promoter	NULL
activity	NULL
and	NULL
IL-2	NULL
responsiveness	NULL
among	NULL
the	NULL
plasmids	NULL
of	NULL
this	NULL
series	NULL
(	NULL
see	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
segment	NULL
defined	NULL
by	NULL
deletions	NULL
AC3.1	NULL
,	NULL
AC3.2	NULL
,	NULL
and	NULL
AC3.3	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
IL-2-inducible	NULL
enhancer	NULL
activity	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
we	NULL
inserted	NULL
the	NULL
fragment	NULL
between	NULL
nucleotides	NULL
-1406	NULL
and	NULL
-1301	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
B-globin	NULL
promoter	NULL
of	NULL
pG1	NULL
(	NULL
37	NULL
)	NULL
that	NULL
does	NULL
not	NULL
respond	NULL
to	NULL
stimulation	NULL
by	NULL
IL-2	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
,	NULL
pG1.C3	NULL
,	NULL
10747	NULL
responds	NULL
to	NULL
IL-2	NULL
as	NULL
well	NULL
as	NULL
pG1.BC	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
entire	NULL
segment	NULL
B+C	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
segment	NULL
C2	NULL
,	NULL
in	NULL
plasmid	NULL
pG1.C2+C3	NULL
,	NULL
does	NULL
not	NULL
significantly	NULL
improve	NULL
IL-2	NULL
inducibility	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
mapped	NULL
the	NULL
elements	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
by	NULL
scanning	NULL
the	NULL
segments	NULL
C3.1	NULL
,	NULL
C3.2	NULL
,	NULL
and	NULL
C.3.3	NULL
with	NULL
a	NULL
series	NULL
of	NULL
mutations	NULL
involving	NULL
4-9	NULL
nucleotides	NULL
each	NULL
.	NULL

The	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
show	NULL
that	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
pwt	NULL
depends	NULL
on	NULL
three	NULL
separate	NULL
stretches	NULL
that	NULL
are	NULL
between	NULL
6	NULL
and	NULL
12	NULL
nucleotides	NULL
long	NULL
.	NULL

These	NULL
sites	NULL
are	NULL
defined	NULL
by	NULL
mutations	NULL
M4	NULL
,	NULL
M5	NULL
,	NULL
and	NULL
M6	NULL
(	NULL
site	NULL
I	NULL
)	NULL
,	NULL
mutation	NULL
M9	NULL
(	NULL
site	NULL
II	NULL
)	NULL
and	NULL
mutations	NULL
M12	NULL
and	NULL
M13	NULL
(	NULL
site	NULL
III	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
them	NULL
presumably	NULL
corresponds	NULL
to	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
(	NULL
see	NULL
``	NULL
Discussion	NULL
``	NULL
)	NULL
.	NULL

IL-1	NULL
Response	NULL
Elements-The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
demonstrate	NULL
that	NULL
removal	NULL
of	NULL
segment	NULL
C	NULL
does	NULL
not	NULL
abolish	NULL
IL-1	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
indicate	NULL
that	NULL
the	NULL
early	NULL
protein	NULL
synthesis-independent	NULL
response	NULL
of	NULL
the	NULL
genomic	NULL
IL-2Ra	NULL
gene	NULL
to	NULL
IL-1	NULL
requires	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
studies	NULL
on	NULL
the	NULL
human	NULL
promoter	NULL
proximal	NULL
region	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IL-1	NULL
response	NULL
mediated	NULL
by	NULL
this	NULL
segment	NULL
depended	NULL
on	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
kBI1	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

This	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
deletions	NULL
in	NULL
the	NULL
conserved	NULL
promoter	NULL
proximal	NULL
region	NULL
on	NULL
the	NULL
IL-1	NULL
responsiveness	NULL
of	NULL
the	NULL
mouse	NULL
gene	NULL
.	NULL

Since	NULL
stimulation	NULL
of	NULL
PC6O	NULL
with	NULL
IL-1	NULL
induces	NULL
secretion	NULL
of	NULL
IL-2	NULL
,	NULL
we	NULL
used	NULL
for	NULL
these	NULL
experiments	NULL
recombinants	NULL
that	NULL
had	NULL
been	NULL
made	NULL
IL-2	NULL
unresponsive	NULL
by	NULL
the	NULL
removal	NULL
of	NULL
region	NULL
C.	NULL
Fig	NULL
.	NULL

6B	NULL
compares	NULL
the	NULL
constitutive	NULL
expression	NULL
and	NULL
IL-1	NULL
responsiveness	NULL
of	NULL
plasmids	NULL
missing	NULL
various	NULL
segments	NULL
of	NULL
the	NULL
region	NULL
between	NULL
position	NULL
-585	NULL
and	NULL
-54	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
ratio	NULL
between	NULL
reference	NULL
plasmid	NULL
and	NULL
IL-2Ra	NULL
«	NULL
recombinant	NULL
is	NULL
not	NULL
the	NULL
same	NULL
in	NULL
all	NULL
the	NULL
transfections	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

It	NULL
should	NULL
also	NULL
be	NULL
pointed	NULL
out	NULL
that	NULL
the	NULL
normalization	NULL
of	NULL
signals	NULL
derived	NULL
from	NULL
IL-2Ra	NULL
«	NULL
recombinant	NULL
transcripts	NULL
(	NULL
¢	NULL
)	NULL
to	NULL
the	NULL
signals	NULL
derived	NULL
from	NULL
reference	NULL
plasmid	NULL
mRNA	NULL
(	NULL
r	NULL
)	NULL
is	NULL
very	NULL
precise	NULL
and	NULL
allows	NULL
reliable	NULL
determination	NULL
of	NULL
2-fold	NULL
inductions	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
plasmid	NULL
containing	NULL
an	NULL
intact	NULL
D	NULL
region	NULL
(	NULL
pRAC	NULL
)	NULL
is	NULL
increased	NULL
about	NULL
5-fold	NULL
by	NULL
stimulation	NULL
with	NULL
IL-1	NULL
.	NULL

Deletion	NULL
AD3	NULL
completely	NULL
abolishes	NULL
this	NULL
response	NULL
,	NULL
indicating	NULL
that	NULL
all	NULL
IL-l-responsive	NULL
elements	NULL
in	NULL
pRAC	NULL
are	NULL
contained	NULL
in	NULL
the	NULL
segment	NULL
between	NULL
positions	NULL
-585	NULL
and	NULL
-54	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
plasmid	NULL
pRACAD3	NULL
is	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
of	NULL
pRAC	NULL
.	NULL

Deletion	NULL
AD4	NULL
,	NULL
which	NULL
removes	NULL
23	NULL
bp	NULL
,	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
xB1	NULL
)	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
genes	NULL
,	NULL
reduces	NULL
IL-1	NULL
responsiveness	NULL
to	NULL
2-3-fold	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
segment	NULL
5	NULL
of	NULL
this	NULL
stretch	NULL
(	NULL
AD1	NULL
)	NULL
reduces	NULL
responsiveness	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
AD4	NULL
,	NULL
indicating	NULL
that	NULL
elements	NULL
upstream	NULL
of	NULL
the	NULL
conserved	NULL
NF-kB	NULL
site	NULL
are	NULL
required	NULL
for	NULL
a	NULL
complete	NULL
IL-1	NULL
response	NULL
.	NULL

Deletion	NULL
AD6	NULL
does	NULL
not	NULL
reduce	NULL
IL-1	NULL
responsiveness	NULL
,	NULL
confirming	NULL
that	NULL
elements	NULL
between	NULL
position	NULL
-585	NULL
and	NULL
-246	NULL
contribute	NULL
most	NULL
of	NULL
the	NULL
response	NULL
.	NULL

However	NULL
,	NULL
the	NULL
plasmid	NULL
with	NULL
the	NULL
complementary	NULL
deletion	NULL
,	NULL
AD2	NULL
,	NULL
still	NULL
responds	NULL
reproducibly	NULL
,	NULL
albeit	NULL
weakly	NULL
,	NULL
to	NULL
IL-1	NULL
,	NULL
indicating	NULL
that	NULL
elements	NULL
downstream	NULL
of	NULL
B1	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
IL-1	NULL
response	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
.	NULL

The	NULL
increased	NULL
base-line	NULL
expression	NULL
of	NULL
pRACAD1	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
the	NULL
conserved	NULL
negative	NULL
regulatory	NULL
element-2	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
that	NULL
reduces	NULL
expression	NULL
of	NULL
human	NULL
IL-2R	NULL
«	NULL
constructs	NULL
in	NULL
phorbol	NULL
12-myristate	NULL
13-acetate-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
,	NULL
but	NULL
in	NULL
this	NULL
case	NULL
,	NULL
pRACAD2	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
show	NULL
a	NULL
similarly	NULL
increased	NULL
constitutive	NULL
activity	NULL
.	NULL

Promoter	NULL
Proximal	NULL
Elements	NULL
Are	NULL
Not	NULL
Essential	NULL
for	NULL
IL-2	NULL
Responsiveness-Testing	NULL
the	NULL
effect	NULL
of	NULL
deletions	NULL
AD1I-AD6	NULL
on	NULL
the	NULL
IL-2	NULL
response	NULL
of	NULL
plasmids	NULL
containing	NULL
an	NULL
intact	NULL
C	NULL
region	NULL
in	NULL
IL-1-primed	NULL
cells	NULL
we	NULL
found	NULL
that	NULL
none	NULL
of	NULL
these	NULL
deletions	NULL
abolish	NULL
the	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
although	NULL
some	NULL
markedly	NULL
reduce	NULL
it	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
IL-2	NULL
response	NULL
elements	NULL
in	NULL
segment	NULL
10748	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
A	NULL
CS	NULL
___	NULL
C	NULL
``	NULL
2539	NULL
+1972-1835	NULL
402	NULL
+83	NULL
1	NULL
2	NULL
s	NULL
s	NULL
_s	NULL
a	NULL
(	NULL
&	NULL
*	NULL
ge-pwt	NULL
-	NULL
|	NULL
C	NULL
[	NULL
s	NULL
}	NULL
c	NULL
1	NULL
o	NULL
T	NULL
H_P	NULL
x	NULL
not	NULL
primed	NULL
|	NULL
primed	NULL
y*	NULL
``	NULL
e	NULL
I7	NULL
I	NULL
I	NULL
m	NULL
1.0	NULL
ess	NULL
%	NULL
pwt	NULL
-a-	NULL
|	NULL
26	NULL
«	NULL
1835	NULL
«	NULL
401	NULL
6	NULL
4*	NULL
pRAC	NULL
(	NULL
--	NULL
--	NULL
--	NULL
-3	NULL
-=	NULL
-3	NULL
pRaGca	NULL
]	NULL
|	NULL
_e-	NULL
|	NULL
hoe	NULL
|	NULL
_	NULL
,	NULL
.	NULL

Conserved	NULL
promoter-proximal	NULL
region	NULL
BE	NULL
B1	NULL
repeat	NULL
C	NULL
mt	NULL
repeat	NULL
‘	NULL
3	NULL
g	NULL
0.8	NULL
'D	NULL
‘	NULL
|	NULL
©	NULL
c	NULL
y	NULL
E	NULL
:	NULL
$	NULL
f	NULL
Ba	NULL
-	NULL
o6	NULL
9	NULL
o	NULL
a	NULL
.	NULL

§	NULL
Cells	NULL
:	NULL
PRIMED	NULL
NOT	NULL
PRIMED	NULL
=	NULL
§	NULL
CC	NULL
.N	NULL
a	NULL
4	NULL
5	NULL
a	NULL
=	NULL
0.4	NULL
|	NULL
Plasmid	NULL
:	NULL
pR	NULL
pRAC	NULL
pR	NULL
pRAC	NULL
a	NULL
€	NULL
in	NULL
:	NULL
Ah	NULL
sad	NULL
a0¢-	NULL
+0	NULL
y-	NULL
5	NULL
p	NULL
|	NULL
Interleukin	NULL
:	NULL
o	NULL
+	NULL
o	NULL
+	NULL
o	NULL
+	NULL
o	NULL
``	NULL
+	NULL
9	NULL
¥	NULL
.	NULL

/-~	NULL
0.21	NULL
o	NULL
``	NULL
H	NULL
th	NULL
y	NULL
.\_/	NULL
.	NULL

gue	NULL
sane	NULL
scr	NULL
noice	NULL
see	NULL
nome	NULL
nees	NULL
come	NULL
gig	NULL
o	NULL
mer	NULL
<	NULL
>	NULL
ip	NULL
TWL	NULL
'	NULL
?	NULL

--	NULL
--	NULL
--	NULL
-	NULL
|	NULL
i	NULL
>	NULL
so	NULL
,	NULL
_	NULL
|	NULL
r	NULL
3	NULL
esas	NULL
hange	NULL
:	NULL
toed	NULL
.	NULL

Mee	NULL
hie	NULL
iver	NULL
Yore	NULL
0	NULL
10	NULL
20	NULL
___	NULL
30	NULL
40	NULL
50	NULL
Hours	NULL
of	NULL
induction	NULL
stimuLus	NULL
:	NULL
Plasmid	NULL
:	NULL
pwt	NULL
pRAC3	NULL
I	NULL
U	NULL
I	NULL
§	NULL
-~	NULL
H	NULL
-	NULL
IL-2	NULL
[	NULL
h	NULL
]	NULL
:	NULL
O0	NULL
1	NULL
3	NULL
5	NULL
8	NULL
10	NULL
24	NULL
3648	NULL
0	NULL
1	NULL
3	NULL
8	NULL
24	NULL
48	NULL
c	NULL
c	NULL
30	NULL
=	NULL
£	NULL
O	NULL
i	NULL
3	NULL
a	NULL
o	NULL
P	NULL
#	NULL
3	NULL
20	NULL
112	NULL
1	NULL
>	NULL
c	NULL
E	NULL
é	NULL
:	NULL
10	NULL
O	NULL
race	NULL
r	NULL
-	NULL
>	NULL
3	NULL
8	NULL
E	NULL
``	NULL
o	NULL
3	NULL
33	NULL
13.8	NULL
22.0	NULL
|	NULL
19	NULL
1.8	NULL
150	NULL
7.0	NULL
25	NULL
127	NULL
63	NULL
17	NULL
67	NULL
Range	NULL
31	NULL
129198	NULL
|	NULL
14	NULL
12	NULL
12	NULL
0	NULL
39	NULL
24	NULL
116	NULL
-	NULL
55	NULL
12	NULL
44	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

The	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
controls	NULL
transcriptional	NULL
responses	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
.	NULL

A	NULL
,	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
and	NULL
IL-2Ro/rabbit	NULL
-globin	NULL
reporter	NULL
gene	NULL
recombinants	NULL
.	NULL

Note	NULL
that	NULL
nucleotide	NULL
numbering	NULL
is	NULL
changed	NULL
with	NULL
respect	NULL
to	NULL
previous	NULL
publications	NULL
(	NULL
11	NULL
,	NULL
29	NULL
)	NULL
to	NULL
start	NULL
at	NULL
the	NULL
major	NULL
cap	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
of	NULL
IL-2Ra	NULL
transcripts	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
61	NULL
)	NULL
as	NULL
well	NULL
as	NULL
normal	NULL
mature	NULL
T	NULL
cells	NULL
and	NULL
thymocytes	NULL
.	NULL

In	NULL
the	NULL
top	NULL
representation	NULL
are	NULL
also	NULL
indicated	NULL
the	NULL
positions	NULL
of	NULL
repetitive	NULL
elements	NULL
.	NULL

Plasmid	NULL
pwt	NULL
contains	NULL
the	NULL
-2539/+93	NULL
(	NULL
SpAI	NULL
(	NULL
S	NULL
)	NULL
to	NULL
PstI	NULL
(	NULL
P	NULL
)	NULL
)	NULL
segment	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
.	NULL

The	NULL
segment	NULL
is	NULL
subdivided	NULL
into	NULL
regions	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
and	NULL
D	NULL
,	NULL
separated	NULL
by	NULL
Bg/II	NULL
sites	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Plasmid	NULL
pR	NULL
is	NULL
identical	NULL
to	NULL
pwt	NULL
except	NULL
for	NULL
restriction	NULL
sites	NULL
that	NULL
have	NULL
been	NULL
inserted	NULL
into	NULL
the	NULL
Bg/II	NULL
sites	NULL
(	NULL
H	NULL
,	NULL
HindIII	NULL
;	NULL
X	NULL
,	NULL
Xbal	NULL
;	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
.	NULL

In	NULL
pRAC	NULL
,	NULL
the	NULL
entire	NULL
C	NULL
segment	NULL
is	NULL
deleted	NULL
.	NULL

B	NULL
,	NULL
interleukin	NULL
response	NULL
pattern	NULL
of	NULL
IL-2Ra/rabbit	NULL
B-globin	NULL
reporter	NULL
gene	NULL
recombinants	NULL
.	NULL

PC6O	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
normal	NULL
medium	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-1	NULL
for	NULL
3	NULL
days	NULL
prior	NULL
to	NULL
transfection	NULL
.	NULL

Nonstimulated	NULL
or	NULL
IL-1-primed	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
the	NULL
indicated	NULL
IL-2Ra	NULL
construct	NULL
,	NULL
and	NULL
a	NULL
reference	NULL
plasmid	NULL
carrying	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
the	NULL
same	NULL
reporter	NULL
gene	NULL
joined	NULL
to	NULL
the	NULL
constitutive	NULL
rabbit	NULL
B-actin	NULL
promoter	NULL
(	NULL
pGBAcBGID	NULL
or	NULL
ref	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
aliquots	NULL
that	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
indicated	NULL
interleukins	NULL
for	NULL
48	NULL
h.	NULL
Reporter	NULL
gene	NULL
transcripts	NULL
were	NULL
revealed	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
-globin	NULL
cDNA	NULL
according	NULL
to	NULL
Ref	NULL
.	NULL

34	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
IL-2R	NULL
«	NULL
(	NULL
i	NULL
)	NULL
to	NULL
reference	NULL
signal	NULL
(	NULL
r	NULL
)	NULL
,	NULL
determined	NULL
with	NULL
a	NULL
PhosphorImager	NULL
,	NULL
is	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
corresponding	NULL
IL-2Ra	NULL
«	NULL
construct	NULL
.	NULL

By	NULL
comparing	NULL
this	NULL
normalized	NULL
promoter	NULL
activity	NULL
in	NULL
unstimulated	NULL
and	NULL
interleukin-stimulated	NULL
cells	NULL
,	NULL
one	NULL
can	NULL
quantify	NULL
the	NULL
interleukin	NULL
response	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
recombinant	NULL
.	NULL

The	NULL
values	NULL
shown	NULL
represent	NULL
means	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
ranges	NULL
below	NULL
each	NULL
column	NULL
.	NULL

C	NULL
and	NULL
D	NULL
,	NULL
kinetics	NULL
of	NULL
the	NULL
IL-2	NULL
response	NULL
of	NULL
IL-2Ra	NULL
«	NULL
5'-FR/B-globin	NULL
reporter	NULL
gene	NULL
recombinants	NULL
.	NULL

Primed	NULL
or	NULL
unstimulated	NULL
PC6O	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
0.4	NULL
pmol	NULL
of	NULL
the	NULL
reference	NULL
plasmid	NULL
and	NULL
2	NULL
pmol	NULL
of	NULL
IL-2R	NULL
«	NULL
5'-FR/B-globin	NULL
recombinants	NULL
pwt	NULL
or	NULL
pRAC3	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
either	NULL
in	NULL
normal	NULL
medium	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-1	NULL
for	NULL
48	NULL
h.	NULL
IL-2	NULL
was	NULL
added	NULL
to	NULL
individual	NULL
cultures	NULL
to	NULL
be	NULL
present	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
prior	NULL
to	NULL
harvest	NULL
and	NULL
RNA	NULL
extraction	NULL
and	NULL
assay	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
IL-2Ra	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
shown	NULL
(	NULL
D	NULL
)	NULL
represents	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
primed	NULL
cells	NULL
.	NULL

C	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
sequences	NULL
between	NULL
position	NULL
-585	NULL
and	NULL
-54	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
segment	NULL
C3	NULL
can	NULL
confer	NULL
IL-2	NULL
responsiveness	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
AD2	NULL
does	NULL
not	NULL
significantly	NULL
alter	NULL
IL-2	NULL
responsiveness	NULL
argues	NULL
against	NULL
any	NULL
role	NULL
for	NULL
NF-kB	NULL
in	NULL
this	NULL
response	NULL
since	NULL
computer	NULL
searches	NULL
have	NULL
not	NULL
revealed	NULL
any	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
site	NULL
in	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
5'-FR	NULL
apart	NULL
from	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B2	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

6A	NULL
for	NULL
definition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
site	NULL
)	NULL
.	NULL

DISCUSSION	NULL
PC6O	NULL
Is	NULL
a	NULL
Model	NULL
for	NULL
Normal	NULL
CD4~CD8~	NULL
Thymocytes-We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
IL-1	NULL
and	NULL
IL-2	NULL
synergize	NULL
to	NULL
induce	NULL
IL-2R	NULL
«	NULL
mRNA	NULL
levels	NULL
and	NULL
surface	NULL
expression	NULL
in	NULL
normal	NULL
CD4~CD8~	NULL
thymocytes	NULL
.	NULL

Analysis	NULL
of	NULL
transgenic	NULL
mice	NULL
lines	NULL
(	NULL
65	NULL
)	NULL
demonstrated	NULL
that	NULL
this	NULL
regulation	NULL
depends	NULL
on	NULL
the	NULL
5'-FR	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
used	NULL
a	NULL
CD4~CD8~	NULL
cell	NULL
line	NULL
whose	NULL
response	NULL
to	NULL
IL-1	NULL
and	NULL
IL-2	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
normal	NULL
cells	NULL
with	NULL
the	NULL
same	NULL
phenotype	NULL
to	NULL
analyze	NULL
more	NULL
closely	NULL
the	NULL
mechanisms	NULL
that	NULL
mediate	NULL
interleukin	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
and	NULL
to	NULL
localize	NULL
the	NULL
cis-acting	NULL
elements	NULL
controlling	NULL
it	NULL
.	NULL

Since	NULL
these	NULL
cells	NULL
do	NULL
not	NULL
depend	NULL
on	NULL
interleukins	NULL
for	NULL
growth	NULL
or	NULL
survival	NULL
,	NULL
the	NULL
responses	NULL
analyzed	NULL
are	NULL
not	NULL
the	NULL
indirect	NULL
consequences	NULL
of	NULL
the	NULL
growth	NULL
factor	NULL
activity	NULL
of	NULL
these	NULL
interleukins	NULL
.	NULL

Stimulation	NULL
of	NULL
PC6O	NULL
cells	NULL
with	NULL
IL-1	NULL
+	NULL
IL-2	NULL
induces	NULL
a	NULL
biphasic	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
«	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
first	NULL
phase	NULL
is	NULL
a	NULL
protein	NULL
synthesis-independent	NULL
response	NULL
to	NULL
IL-1	NULL
that	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
second	NULL
phase	NULL
is	NULL
due	NULL
mainly	NULL
to	NULL
IL-2	NULL
and	NULL
starts	NULL
at	NULL
about	NULL
10	NULL
h.	NULL
This	NULL
delay	NULL
is	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
unstimulated	NULL
cells	NULL
respond	NULL
very	NULL
slowly	NULL
to	NULL
IL-2	NULL
alone	NULL
,	NULL
whereas	NULL
stimulation	NULL
with	NULL
IL-1	NULL
induces	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

This	NULL
priming	NULL
effect	NULL
reflects	NULL
,	NULL
most	NULL
likely	NULL
,	NULL
a	NULL
rise	NULL
in	NULL
IL-2Ra	NULL
«	NULL
and	NULL
IL-2RB	NULL
expression	NULL
that	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
high	NULL
affinity	NULL
IL-2R	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
interleukin	NULL
induced	NULL
rise	NULL
in	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
10749	NULL
A	NULL
C	NULL
ass	NULL
aste	NULL
mss	NULL
ae	NULL
an	NULL
ags	NULL
IL-2	NULL
response	NULL
£	NULL
&	NULL
$	NULL
£	NULL
``	NULL
Plasmid	NULL
:	NULL
(	NULL
fold	NULL
stimulation	NULL
)	NULL
pwt	NULL
C	NULL
A	NULL
[	NULL
§	NULL
c	NULL
I	NULL
0	NULL
[	NULL
3	NULL
hez	NULL
x	NULL
mall	NULL
pR	NULL
pGi	NULL
1.2	NULL
«	NULL
1805	NULL
160	NULL
«	NULL
1972	NULL
#	NULL
2	NULL
pRAC1	NULL
LZZZZZIZIZIIIZZ	NULL
ZGZZZLZLLLLLLLLLLLLLLLLLLLLLLLLZLLZL	NULL
pG1.BC	NULL
m	NULL
4.6	NULL
1636	NULL
«	NULL
1384	NULL
f	NULL
.	NULL

pRAC2	NULL
-	NULL
«	NULL
sot	NULL
yas	NULL
in	NULL
pai.c2+C3	NULL
Fzxzzz22	NULL
5.4	NULL
pRACs	NULL
WPL	NULL
TTT	NULL
ITI	NULL
®	NULL
®	NULL
saat	NULL
.	NULL

oes	NULL
«	NULL
sos	NULL
«	NULL
rao	NULL
pRAC4	NULL
2222777777777	NULL
77777774	NULL
TII	NULL
a1.C	NULL
2	NULL
5.5	NULL
ose	NULL
.	NULL

G97	NULL
pG1.C3	NULL
®	NULL
pRACS	NULL
-	NULL
1277777717777777773	NULL
-1988	NULL
Pal	NULL
paBC	NULL
-	NULL
(	NULL
222277777	NULL
ITI	NULL
TI	NULL
TII	NULL
TI	NULL
x	NULL
2	NULL
H	NULL
pRi	NULL
D	NULL
3	NULL
a	NULL
$	NULL
$	NULL
G	NULL
§	NULL
§o	NULL
2	NULL
5	NULL
505	NULL
§	NULL
G5	NULL
G	NULL
5	NULL
-1383	NULL
-1358	NULL
-1332	NULL
-1306	NULL
85	NULL
o.	NULL
o.	NULL
o.	NULL
o.	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
a.	NULL
csa	NULL
c32	NULL
css	NULL
~o	NULL
804	NULL
]	NULL
000000	NULL
Wo	NULL
|	NULL
o	NULL
c..	NULL
.	NULL

op	NULL
gtactgggaggagtctcctgcaacccag	NULL
ggagtegec	NULL
tctggtctaccaggaagtcgc	NULL
--	NULL
--	NULL
--	NULL
--	NULL
$	NULL
5	NULL
Mutant	NULL
:	NULL
{	NULL
if	NULL
Al	NULL
_	NULL
M2	NULL
MG	NULL
M4	NULL
MS	NULL
M6	NULL
M7	NULL
M8	NULL
x9	NULL
M10	NULL
Mil	NULL
M12	NULL
M13	NULL
mid	NULL
|	NULL
Ais	NULL
S	NULL
$	NULL
6	NULL
»	NULL
12	NULL
aa	NULL
Responses	NULL
|	NULL
TB	NULL
0	NULL
608	NULL
5.1	NULL
1.6	NULL
1.2	NULL
2.1	NULL
5.7	NULL
6.500	NULL
1.5	NULL
6.6	NULL
325	NULL
1.1	NULL
1.90	NULL
62.8	NULL
33	NULL
&	NULL
~£	NULL
I	NULL
II	NULL
III	NULL
~	NULL
10	NULL
_	NULL
zts-1	NULL
:	NULL
(	NULL
hem	NULL
o	NULL
a	NULL
cans	NULL
:	NULL
Reo	NULL
Range	NULL
:	NULL
-	NULL
128	NULL
1.2	NULL
146	NULL
18.7	NULL
189	NULL
54	NULL
15°	NULL
267	NULL
121	NULL
iP	NULL
stam	NULL
:	NULL
[	NULL
___	NULL
]	NULL
152	NULL
1.5	NULL
20.5	NULL
23.0	NULL
32.0	NULL
10.8	NULL
18	NULL
37.3	NULL
17.7	NULL
ip	NULL
B	NULL
IL-2	NULL
:	NULL
I	NULL
f	NULL
Fix	NULL
or	NULL
aay	NULL
c	NULL
aora	NULL
ra	NULL
ss	NULL
3	NULL
oo	NULL
a	NULL
ale	NULL
k	NULL
a	NULL
%	NULL
s	NULL
+	NULL
n	NULL
%	NULL
we	NULL
Al	NULL
M2	NULL
M3	NULL
M4	NULL
M5	NULL
M6	NULL
M7	NULL
M8	NULL
M9	NULL
M10	NULL
Mil	NULL
M12	NULL
M13	NULL
mid	NULL
Ais	NULL
1389	NULL
228	NULL
cA	NULL
TET	NULL
Fe-	NULL
63	NULL
1389	NULL
208	NULL
pRAC3	NULL
i	NULL
==	NULL
--	NULL
-+1386	NULL
.	NULL

1987	NULL
pAC3.1	NULL
i	NULL
+1380	NULL
.	NULL

paCB2	NULL
E-	NULL
]	NULL
C	NULL
--	NULL
--	NULL
--	NULL
5	NULL
.	NULL

(	NULL
1305	NULL
pAC3.3	NULL
+1306	NULL
.	NULL

1978	NULL
pAC3.4	NULL
I	NULL
.	NULL

oats	NULL
pac3.s	NULL
mass	NULL
(	NULL
esd	NULL
pACB.6	NULL
EO	NULL
~~	NULL
f	NULL
[	NULL
LLCO	NULL
pwt	NULL
pRAC3	NULL
paC3.1	NULL
pAC3.2	NULL
paC3.3	NULL
paC3.4	NULL
paC3.5	NULL
pAC3.6	NULL
IL-2	NULL
response	NULL
(	NULL
fold	NULL
stimulation	NULL
)	NULL
in	NULL
0	NULL
Range	NULL
:	NULL
7.7	NULL
08	NULL
08	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Mapping	NULL
of	NULL
IL-2	NULL
responsive	NULL
elements	NULL
in	NULL
segment	NULL
C.	NULL
A	NULL
,	NULL
the	NULL
sequences	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
lie	NULL
between	NULL
bp	NULL
-1389	NULL
and	NULL
-1228	NULL
.	NULL

The	NULL
indicated	NULL
IL-2Ro/B-globin	NULL
recombinants	NULL
were	NULL
transfected	NULL
into	NULL
IL-1	NULL
primed	NULL
PC6O0	NULL
cells	NULL
together	NULL
with	NULL
reference	NULL
plasmid	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
5:1	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
IL-1	NULL
with	NULL
or	NULL
without	NULL
IL-2	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
constructs	NULL
is	NULL
determined	NULL
by	NULL
normalizing	NULL
the	NULL
corresponding	NULL
mRNA	NULL
signal	NULL
to	NULL
that	NULL
from	NULL
the	NULL
cotransfected	NULL
reference	NULL
plasmid	NULL
.	NULL

The	NULL
IL-2	NULL
response	NULL
is	NULL
the	NULL
ratio	NULL
between	NULL
promoter	NULL
activity	NULL
after	NULL
culture	NULL
in	NULL
IL-1	NULL
+	NULL
IL-2	NULL
and	NULL
the	NULL
activity	NULL
after	NULL
culture	NULL
in	NULL
IL-1	NULL
alone	NULL
.	NULL

Indicated	NULL
is	NULL
the	NULL
mean	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
with	NULL
ranges	NULL
given	NULL
below	NULL
each	NULL
bar	NULL
.	NULL

Base-line	NULL
promoter	NULL
activity	NULL
(	NULL
in	NULL
IL-1	NULL
only	NULL
)	NULL
of	NULL
the	NULL
different	NULL
IL-2Ra	NULL
«	NULL
constructs	NULL
,	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
pwt	NULL
(	NULL
=1	NULL
)	NULL
,	NULL
varied	NULL
within	NULL
the	NULL
following	NULL
ranges	NULL
:	NULL
pABC	NULL
,	NULL
1.4-1.5	NULL
;	NULL
pR	NULL
,	NULL
0.6-0.8	NULL
;	NULL
pRi	NULL
,	NULL
0.3-0.5	NULL
;	NULL
pRAC1	NULL
,	NULL
0.2-0.3	NULL
;	NULL
pRAC2	NULL
,	NULL
0.3-0.5	NULL
;	NULL
pRAC3	NULL
,	NULL
1.6-1.7	NULL
;	NULL
pRACA4	NULL
,	NULL
0.4-0.5	NULL
;	NULL
pRACS5	NULL
,	NULL
1.0-1.5	NULL
.	NULL

B	NULL
,	NULL
IL-2	NULL
responsiveness	NULL
is	NULL
controlled	NULL
by	NULL
75	NULL
bp	NULL
in	NULL
segment	NULL
C3	NULL
.	NULL

IL-2	NULL
responses	NULL
of	NULL
the	NULL
different	NULL
plasmids	NULL
were	NULL
determined	NULL
as	NULL
in	NULL
A.	NULL
Base-line	NULL
expressions	NULL
,	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
pwt	NULL
,	NULL
ranged	NULL
as	NULL
follows	NULL
:	NULL
pRAC3	NULL
,	NULL
1.5-2.0	NULL
;	NULL
pRAC3.1	NULL
,	NULL
1.1-1.8	NULL
;	NULL
pRAC3.2	NULL
,	NULL
0.6-1.0	NULL
;	NULL
pRAC3.3	NULL
,	NULL
0.9-1.6	NULL
;	NULL
pRAC3.4	NULL
,	NULL
0.9-1.3	NULL
;	NULL
pRAC3.5	NULL
,	NULL
1.0	NULL
;	NULL
pRAC3.6	NULL
,	NULL
1.9-3.0	NULL
.	NULL

C	NULL
,	NULL
segment	NULL
C3	NULL
acts	NULL
as	NULL
an	NULL
IL-2	NULL
responsive	NULL
enhancer	NULL
.	NULL

Single	NULL
copies	NULL
of	NULL
different	NULL
portions	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
-flanking	NULL
region	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
-globin	NULL
promoter	NULL
of	NULL
pG1	NULL
.	NULL

IL-2	NULL
responses	NULL
of	NULL
the	NULL
different	NULL
plasmids	NULL
were	NULL
determined	NULL
as	NULL
in	NULL
A	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
means	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

The	NULL
responses	NULL
varied	NULL
by	NULL
less	NULL
than	NULL
20	NULL
%	NULL
.	NULL

Mean	NULL
base-line	NULL
expressions	NULL
,	NULL
normalized	NULL
to	NULL
that	NULL
of	NULL
pGBAcBGID	NULL
(	NULL
reference	NULL
plasmid	NULL
)	NULL
,	NULL
were	NULL
0.06	NULL
(	NULL
pG1	NULL
)	NULL
,	NULL
0.06	NULL
(	NULL
pG1.BC	NULL
)	NULL
,	NULL
0.15	NULL
(	NULL
pG1.C2+C3	NULL
)	NULL
and	NULL
0.12	NULL
(	NULL
pG1.C3	NULL
)	NULL
.	NULL

D	NULL
,	NULL
three	NULL
separate	NULL
elements	NULL
in	NULL
the	NULL
enhancer	NULL
are	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

Below	NULL
the	NULL
sequence	NULL
of	NULL
segments	NULL
C3.1	NULL
,	NULL
C3.2	NULL
and	NULL
C3.3	NULL
are	NULL
indicated	NULL
the	NULL
14	NULL
mutations	NULL
that	NULL
were	NULL
introduced	NULL
into	NULL
pwt	NULL
(	NULL
das/	NULL
,	NULL
deletion	NULL
;	NULL
lowercase	NULL
letter	NULL
,	NULL
substitution	NULL
)	NULL
and	NULL
the	NULL
IL-2	NULL
responses	NULL
of	NULL
the	NULL
corresponding	NULL
plasmids	NULL
.	NULL

The	NULL
mean	NULL
of	NULL
two	NULL
experiments	NULL
is	NULL
given	NULL
,	NULL
and	NULL
the	NULL
result	NULL
of	NULL
a	NULL
single	NULL
experiment	NULL
is	NULL
shown	NULL
below	NULL
.	NULL

IL-2	NULL
inducibility	NULL
varied	NULL
by	NULL
less	NULL
than	NULL
20	NULL
%	NULL
between	NULL
experiments	NULL
.	NULL

I	NULL
,	NULL
IZ	NULL
,	NULL
and	NULL
III	NULL
indicate	NULL
the	NULL
separate	NULL
elements	NULL
mutations	NULL
in	NULL
which	NULL
abolish	NULL
IL-2	NULL
inducibility	NULL
.	NULL

Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
10750	NULL
aouaugjor	NULL
wos	NULL
;	NULL
seudts	NULL
'	NULL
@	NULL
'squeurquwooa4	NULL
auad	NULL
xoj10dot	NULL
Suryuey-	NULL
,	NULL
¢g	NULL
woup	NULL
speudts	NULL
yNyu	NULL
@	NULL
9	NULL
'	NULL
(	NULL
¢qvyovyd	NULL
)	NULL
oot	NULL
pue	NULL
'	NULL
(	NULL
qavovud	NULL
reg	NULL
ros	NULL
'ravovud	NULL
'zavovud	NULL
'pvxd	NULL
)	NULL
T:0T	NULL
a	NULL
«	NULL
om	NULL
pruserd	NULL
aduargjo	NULL
pue	NULL
s1ongsuoo	NULL
uoomaq	NULL
soe	NULL
ayy	NULL
,	NULL
quawntadxa	NULL
uonoo	NULL
;	NULL
sue	NULL
.	NULL

auo	NULL
wou	NULL
;	NULL
ypu	NULL
'	NULL
)	NULL
'pageotput	NULL
are	NULL
squawnadxa	NULL
quopuadaput	NULL
aay	NULL
}	NULL
ut	NULL
sonpea	NULL
Jo	NULL
adue.t	NULL
pue	NULL
ueow	NULL
ay	NULL
;	NULL
'pruse	NULL
]	NULL
d	NULL
yorea	NULL
10	NULL
,	NULL
'uotssoudxa	NULL
autf-aseq	NULL
1oa0	NULL
uotssoudxa	NULL
jo	NULL
uor	NULL
;	NULL
enur	NULL
}	NULL
s	NULL
pjoj	NULL
se	NULL
axe	NULL
T-7J	NULL
'T-TJ	NULL
10	NULL
JIm	NULL
U	NULL
gp	NULL
10J	NULL
pain	NULL
}	NULL
[	NULL
no	NULL
adom	NULL
s	NULL
[	NULL
Joo	NULL
«	NULL
ayy	NULL
'y9	NULL
'	NULL
B	NULL
ut	NULL
umoys	NULL
souts	NULL
g-	NULL
[	NULL
N	NULL
omg	NULL
ay	NULL
}	NULL
jo	NULL
suontsod	NULL
ayy	NULL
ageotput	NULL
zg	NULL
»	NULL
pue	NULL
1g	NULL
»	NULL
'	NULL
(	NULL
jo	NULL
uor.od	NULL
e	NULL
se	NULL
[	NULL
Jom	NULL
se	NULL
;	NULL
)	NULL
uot8ou	NULL
yoe|	NULL
Yorym	NULL
'squeurquooa1	NULL
»	NULL
yZ-TI	NULL
pojeotput	NULL
ay3	NULL
pue	NULL
'pruusefd	NULL
aoua.19JoI	NULL
oy	NULL
}	NULL
Jo	NULL
an	NULL
}	NULL
e	NULL
UjIM	NULL
adom	NULL
S	NULL
[	NULL
[	NULL
99	NULL
(	NULL
904	NULL
poje	NULL
{	NULL
nunsuop	NULL
'squawata	NULL
1-7	NULL
;	NULL
jo	NULL
uoneautfop	NULL
'	NULL
g	NULL
'ogz-	NULL
dq	NULL
jo	NULL
ureausdn	NULL
says	NULL
Sutputq	NULL
(	NULL
g1	NULL
'91	NULL
``	NULL
ST	NULL
)	NULL
PU®	NULL
'	NULL
(	NULL
¥¥	NULL
'gH	NULL
)	NULL
(	NULL
x0q-99	NULL
)	NULL
1dg	NULL
'	NULL
(	NULL
61	NULL
)	NULL
JMS	NULL
941	NULL
«	NULL
9J	NULL
Se	NULL
[	NULL
Jo	NULL
Se	NULL
'	NULL
(	NULL
pp	NULL
'6T	NULL
)	NULL
«	NULL
9	NULL
VHZ-II	NULL
AN	NULL
49	NULL
}	NULL
pue	NULL
(	NULL
11	NULL
)	NULL
Z-	NULL
Pue	NULL
(	NULL
$	NULL
9	NULL
)	NULL
T-	NULL
(	NULL
HHN	NULL
)	NULL
squowata	NULL
aareSou	NULL
Jo	NULL
ajo	NULL
A1ojenSa	NULL
e	NULL
10	NULL
aouaptaa	NULL
aaey	NULL
auad	NULL
uetuny	NULL
ayy	NULL
uo	NULL
satpng	NULL
'uontsod	NULL
fue	NULL
ut	NULL
pamo	NULL
[	NULL
[	NULL
e	NULL
auo	NULL
(	NULL
ZQ	NULL
)	NULL
V	NULL
)	NULL
LGYVDI	NULL
ay	NULL
}	NULL
se	NULL
pauyap	NULL
st	NULL
T-JV	NULL
Uy	NULL
'juawdas	NULL
)	NULL
X	NULL
X	NULL
ay	NULL
}	NULL
Ut	NULL
pamo	NULL
[	NULL
[	NULL
e	NULL
YoJEWSsIU	NULL
aud	NULL
YJIM	NULL
(	NULL
£9	NULL
)	NULL
QDAANNNHDDD	NULL
ay	NULL
}	NULL
Jo	NULL
asua.Lin390	NULL
se	NULL
pautJap	NULL
St	NULL
a	NULL
}	NULL
!	NULL

{	NULL
-N	NULL
UV	NULL
(	NULL
Z9	NULL
)	NULL
souonbas	NULL
ay	NULL
}	NULL
[	NULL
JIm	NULL
yoreur	NULL
e	NULL
se	NULL
pouyap	NULL
st	NULL
arts	NULL
Surputq	NULL
YS	NULL
V	NULL
'9T	NULL
'	NULL
g-	NULL
Jo	NULL
on	NULL
[	NULL
ea	NULL
yo-jno	NULL
papuauru0924	NULL
ay	NULL
}	NULL
mojoq	NULL
wewny	NULL
ayy	NULL
ut	NULL
qg-	NULL
uonisod	NULL
12	NULL
xoq	NULL
y.LY	NULL
,	NULL
L	NULL
941	NULL
JO	NULL
(	NULL
08'8g-	NULL
)	NULL
ayy	NULL
,	NULL
'	NULL
(	NULL
Tg	NULL
)	NULL
yong	NULL
4q	NULL
suonduosop	NULL
1jyStom	NULL
ay	NULL
}	NULL
03	NULL
saxoq	NULL
q	NULL
:	NULL
)	NULL
pue	NULL
yy	NULL
,	NULL
,	NULL
'4juo	NULL
pues	NULL
+	NULL
ay	NULL
}	NULL
uo	NULL
10J	NULL
payo.eas	NULL
atom	NULL
saxoq	NULL
y	NULL
.	NULL

'sts4feue	NULL
1onduwoo	NULL
{	NULL
q	NULL
paymuapt	NULL
acom	NULL
si0joe	NULL
;	NULL
10	NULL
soyts	NULL
Surpurq	NULL
snsuasuod	NULL
puse	NULL
soxoq	NULL
y	NULL
,	NULL
[	NULL
V	NULL
,	NULL
J	NULL
,	NULL
'	NULL
(	NULL
TQ9	NULL
)	NULL
'	NULL
I	NULL
»	NULL
72	NULL
4q	NULL
pautunajap	NULL
sajts	NULL
ay	NULL
}	NULL
0	NULL
}	NULL
puodsa.u10o	NULL
paystrqndun	NULL
py	NULL
pue	NULL
Suey	NULL
(	NULL
py	NULL
:	NULL
g	NULL
)	NULL
or	NULL
{	NULL
ooydur	NULL
{	NULL
;	NULL
asnow	NULL
feuntou	NULL
ut	NULL
saqts	NULL
4123s	NULL
uonduosure.s	NULL
saoua1apytp	NULL
1outu	NULL
wou	NULL
;	NULL
qredy	NULL
'smo.in	NULL
Xq	NULL
payeotput	NULL
axe	NULL
soqyts	NULL
dep	NULL
'	NULL
(	NULL
,	NULL
spoyjopyt	NULL
pue	NULL
s	NULL
[	NULL
eLuojepy	NULL
,	NULL
,	NULL
aas	NULL
)	NULL
s1s97	NULL
04	NULL
queoytudts	NULL
areys	NULL
jou	NULL
op	NULL
quad	NULL
asnow	NULL
ay	NULL
}	NULL
ut	NULL
¢gg-	NULL
pur	NULL
(	NULL
z	NULL
UoIS19A	NULL
'pgggT	NULL
Jy	NULL
1oquinu	NULL
uotssaooe	NULL
uewny	NULL
ay	NULL
;	NULL
ut	NULL
ggg-	NULL
suonisod	NULL
jo	NULL
urea1sdn	NULL
saouanbas	NULL
ay	NULL
,	NULL
'soua8	NULL
asnowu	NULL
pue	NULL
uewny	NULL
Jo	NULL
squaw8as	NULL
rewrxoud-19jowo.1d	NULL
ay	NULL
}	NULL
Jo	NULL
asuanbas	NULL
'	NULL
y	NULL
'	NULL
f	NULL
juowSoas	NULL
ut	NULL
squowoto	NULL
aatsuodso	NULL
1-7	NULL
;	NULL
yo	NULL
Surddepy	NULL
'	NULL
9	NULL
'ol	NULL
a	NULL
L-dV	NULL
[	NULL
__	NULL
ll'lx-	NULL
``	NULL
|l	NULL
“	NULL
nllvll	NULL
<	NULL
1	NULL
445	NULL
xoq-	NULL
(	NULL
0s	NULL
ns	NULL
Alt	NULL
woman	NULL
aes	NULL
some	NULL
sn	NULL
nn	NULL
em	NULL
c	NULL
ol	NULL
|	NULL
6	NULL
.	NULL

|	NULL
TOO	NULL
Ces	NULL
)	NULL
*	NULL
B	NULL
#	NULL
4N	NULL
RRR	NULL
|	NULL
SPT+	NULL
LLL	NULL
O1	NULL
L	NULL
UUU	NULL
xou-wiVI	NULL
C	NULL
)	NULL
_	NULL
sst+	NULL
-s	NULL
-x	NULL
-x	NULL
``	NULL
40	NULL
N	NULL
-	NULL
&	NULL
r	NULL
og	NULL
Noob	NULL
r	NULL
og	NULL
Noo	NULL
a	NULL
.	NULL

56	NULL
+	NULL
no	NULL
ro	NULL
no	NULL
N	NULL
LH	NULL
T	NULL
UPR	NULL
OH-	NULL
b	NULL
a	NULL
a	NULL
e	NULL
ud	NULL
t	NULL
UUU	NULL
s	NULL
SYOLOBDYYDDD.LO09L099000	NULL
'	NULL
DOLOYDILLODDDLODNCOYYYONSYODL	NULL
90T+	NULL
gavoved	NULL
savoved	NULL
:	NULL
puseld	NULL
-	NULL
-	NULL
-	NULL
-	NULL
05	NULL
+	NULL
-	NULL
1	NULL
1	NULL
|	NULL
HL	NULL
_	NULL
d	NULL
_	NULL
U	NULL
OH	NULL
TH	NULL
DLLODDDDLOYCDODDYSLODOYONYYYYDDALYDDDD990D	NULL
®	NULL
LODLYOX	NULL
LS	NULL
+	NULL
me	NULL
_	NULL
an	NULL
|	NULL
C	NULL
4	NULL
DLOLLOLLODDDYOLODODYDYOLOYDONONOLNONTOOONEETILON	NULL
'	NULL
OL	NULL
zo	NULL
+	NULL
|	NULL
>	NULL
*	NULL
``	NULL
?	NULL

i	NULL
11	NULL
11	NULL
}	NULL
_i	NULL
T1	NULL
1	NULL
|	NULL
I	NULL
1	NULL
.	NULL

11	NULL
i	NULL
€	NULL
1	NULL
Lo+	NULL
[	NULL
ase	NULL
om	NULL
on-	NULL
c	NULL
dts	NULL
dts	NULL
arts	NULL
aum	NULL
<	NULL
,	NULL
<	NULL
4	NULL
,	NULL
f	NULL
§	NULL
f	NULL
f	NULL
+	NULL
6p	NULL
~	NULL
an	NULL
``	NULL
T	NULL
L_	NULL
L	NULL
TH	NULL
LH	NULL
LLIN	NULL
___	NULL
H	NULL
T	NULL
Nk	NULL
Co	NULL
®	NULL
No-	NULL
!	NULL

mm	NULL
t	NULL
t	NULL
&	NULL
N	NULL
:	NULL
aa	NULL
G	NULL
:	NULL
pp	NULL
no	NULL
no	NULL
no	NULL
no	NULL
-	NULL
-	NULL
<	NULL
!	NULL

<	NULL
-	NULL
tet	NULL
rma	NULL
-	NULL
¥9L09	NULL
*	NULL
LODLLOYYDNDODUL®	NULL
*	NULL
'	NULL
*	NULL
¥	NULL
£6	NULL
savovid	NULL
zavovid	NULL
-	NULL
ovid	NULL
:	NULL
pIWSeId	NULL
iu	NULL
mu	NULL
n	NULL
au	NULL
|	NULL
iu	NULL
iu	NULL
u	NULL
nun	NULL
YSLODOLODDLLLOND	NULL
'	NULL
'	NULL
z6	NULL
-re-	NULL
*	NULL
<	NULL
e	NULL
«	NULL
«	NULL
d	NULL
_	NULL
*	NULL
a	NULL
nc	NULL
PRrormereooveepoporiove	NULL
LET-D	NULL
UTI	NULL
ru	NULL
U	NULL
idont	NULL
t	NULL
DLNDLOL	NULL
CINLONYNDDDDXLLNY	NULL
IPT-*	NULL
98T-g	NULL
'	NULL
(	NULL
rei-og	NULL
)	NULL
g	NULL
:	NULL
--	NULL
--	NULL
-	NULL
``	NULL
L	NULL
HOLE	NULL
HU	NULL
[	NULL
0	NULL
yo	NULL
giz	NULL
gavoved	NULL
®	NULL
cpuaovowoodpx	NULL
06T-	NULL
(	NULL
vod	NULL
)	NULL
pr	NULL
seeu	NULL
pr	NULL
p	NULL
®	NULL
.	NULL

-	NULL
f	NULL
.	NULL

Fo	NULL
Fe	NULL
savoved	NULL
uaumoﬂﬁéuaomﬁ	NULL
ofz-	NULL
(	NULL
ro-e0	NULL
po	NULL
(	NULL
eze	NULL
)	NULL
pz	NULL
Cc	NULL
d	NULL
LH	NULL
UN	NULL
LNL	NULL
L0	NULL
A	NULL
N1	NULL
__L_	NULL
vavovH	NULL
ore-	NULL
@	NULL
Hou	NULL
PL	NULL
(	NULL
1-20	NULL
0°L	NULL
|	NULL
d	NULL
4	NULL
.	NULL

R	NULL
-	NULL
'	NULL
Ll	NULL
eavove	NULL
VODOYOYILOLLOO	NULL
LLL	NULL
®	NULL
YO900000DOLOOLOODDDYOLOD	NULL
S82-	NULL
(	NULL
woso	NULL
90	NULL
(	NULL
veal	NULL
)	NULL
gz	NULL
C	NULL
--	NULL
:	NULL
zavovid	NULL
|LUL	NULL
PTTL	NULL
THIEL	NULL
O0	NULL
TUN	NULL
2avovH	NULL
o	NULL
68¢-	NULL
(	NULL
eed	NULL
gg	NULL
gz	NULL
C	NULL
--	NULL
--	NULL
-~-3	NULL
iavavyd	NULL
&	NULL
#	NULL
veellaN	NULL
___	NULL
Eugoﬁoﬁuogu	NULL
<	NULL
uu¢w	NULL
<	NULL
2oﬁﬁoou§umkﬁgw	NULL
Siovogyo	NULL
seg-HHO	NULL
OLP	NULL
_	NULL
HP	NULL
HH	NULL
I	NULL
}	NULL
(	NULL
oso	NULL
)	NULL
20	NULL
(	NULL
wove	NULL
g	NULL
'	NULL
g	NULL
F	NULL
--	NULL
-	NULL
ovyd	NULL
«	NULL
LLODLOYYDYYODOLOUDONONYSLODDLODLOYYSLNXLLOSNOLOYOIYD	NULL
66¢-SCBl~	NULL
6EST	NULL
6	NULL
*	NULL
k	NULL
§	NULL
6	NULL
10	NULL
DLO	NULL
zes-	NULL
(	NULL
d	NULL
piusejd	NULL
0	NULL
,	NULL
pazijewnou	NULL
)	NULL
|	NULL
(	NULL
uoneinwuns	NULL
pjoj	NULL
)	NULL
I	NULL
11	NULL
L1	NULL
]	NULL
1	NULL
I1	NULL
]	NULL
I	NULL
|	NULL
|	NULL
uotssoidxe	NULL
aurjeseg	NULL
|	NULL
asuodsai	NULL
1-7	NULL
]	NULL
s8¢-seer	NULL
-	NULL
gisl-	NULL
seee	NULL
-	NULL
.	NULL

-	NULL
-	NULL
Ss	NULL
a	NULL
a	NULL
s	NULL
YODLLDDDDDDYODLLODODINDYEYILODYLLLOLONILODLNONSOLNOUL	NULL
stp-i	NULL
E	NULL
]	NULL
[	NULL
a	NULL
]	NULL
v	NULL
]	NULL
md	NULL
I	NULL
IIH	NULL
I	NULL
t	NULL
I	NULL
[	NULL
H	NULL
_	NULL
ie	NULL
s	NULL
L	NULL
©	NULL
f	NULL
A	NULL
rasnoy	NULL
:	NULL
treuny	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

IL-2	NULL
responsiveness	NULL
does	NULL
not	NULL
require	NULL
promoter-proximal	NULL
elements	NULL
.	NULL

IL-1	NULL
primed	NULL
PC6O	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reference	NULL
plasmid	NULL
and	NULL
plasmids	NULL
containing	NULL
an	NULL
intact	NULL
region	NULL
C	NULL
but	NULL
deletions	NULL
in	NULL
segment	NULL
D	NULL
(	NULL
pRAD1L	NULL
to	NULL
pRAD6G	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
interleukins	NULL
.	NULL

Reporter	NULL
gene	NULL
expression	NULL
is	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
cells	NULL
cultured	NULL
in	NULL
normal	NULL
medium	NULL
after	NULL
transfection	NULL
(	NULL
=1	NULL
)	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
tested	NULL
at	NULL
least	NULL
three	NULL
times	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
two	NULL
different	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
entire	NULL
series	NULL
of	NULL
plasmids	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
same	NULL
batch	NULL
of	NULL
primed	NULL
cells	NULL
,	NULL
with	NULL
the	NULL
range	NULL
of	NULL
values	NULL
obtained	NULL
below	NULL
each	NULL
column	NULL
.	NULL

Interleukin	NULL
response	NULL
(	NULL
fold	NULL
stimulation	NULL
)	NULL
t	NULL
o	NULL
IL-2Ra	NULL
mRNA	NULL
is	NULL
due	NULL
mainly	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
in	NULL
this	NULL
paper	NULL
have	NULL
allowed	NULL
us	NULL
to	NULL
map	NULL
the	NULL
cis-acting	NULL
elements	NULL
that	NULL
control	NULL
both	NULL
phases	NULL
of	NULL
mRNA	NULL
increase	NULL
.	NULL

IL-1-responsive	NULL
Elements	NULL
Map	NULL
to	NULL
the	NULL
Conserved	NULL
Promoter	NULL
Proximal	NULL
Region-The	NULL
elements	NULL
that	NULL
account	NULL
for	NULL
the	NULL
direct	NULL
response	NULL
to	NULL
IL-1	NULL
are	NULL
contained	NULL
within	NULL
the	NULL
promoter	NULL
proximal	NULL
segment	NULL
(	NULL
position	NULL
-585	NULL
to	NULL
-54	NULL
)	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

Between	NULL
bp	NULL
-335	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
the	NULL
mouse	NULL
gene	NULL
is	NULL
78	NULL
%	NULL
homologous	NULL
to	NULL
the	NULL
human	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

Within	NULL
this	NULL
segment	NULL
,	NULL
a	NULL
conserved	NULL
motif	NULL
that	NULL
was	NULL
recognized	NULL
as	NULL
a	NULL
NF-kB	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
B1	NULL
)	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
as	NULL
an	NULL
IL-1	NULL
response	NULL
element	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
prevent	NULL
the	NULL
early	NULL
response	NULL
of	NULL
the	NULL
endogenous	NULL
IL-2Ra	NULL
gene	NULL
in	NULL
PC6O	NULL
.	NULL

It	NULL
is	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
study	NULL
in	NULL
which	NULL
the	NULL
human	NULL
5'-FR	NULL
was	NULL
analyzed	NULL
in	NULL
murine	NULL
EL4	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
conserved	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
are	NULL
required	NULL
to	NULL
obtain	NULL
a	NULL
full	NULL
response	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
this	NULL
segment	NULL
(	NULL
D1	NULL
)	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
second	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
«	NULL
B2	NULL
)	NULL
.	NULL

But	NULL
this	NULL
motif	NULL
is	NULL
not	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
,	NULL
and	NULL
it	NULL
seems	NULL
more	NULL
likely	NULL
that	NULL
an	NULL
AP-1	NULL
site	NULL
present	NULL
in	NULL
both	NULL
species	NULL
around	NULL
position	NULL
-335	NULL
contributes	NULL
to	NULL
the	NULL
IL-1	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
AP-1	NULL
elements	NULL
can	NULL
mediate	NULL
IL-1	NULL
responsiveness	NULL
in	NULL
PCSO	NULL
.	NULL

AP-1-dependent	NULL
mRNA	NULL
increases	NULL
are	NULL
slower	NULL
than	NULL
those	NULL
mediated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
are	NULL
not	NULL
yet	NULL
detectable	NULL
after	NULL
4	NULL
h	NULL
of	NULL
IL-1	NULL
treatment	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
mediate	NULL
the	NULL
very	NULL
early	NULL
response	NULL
of	NULL
the	NULL
endogenous	NULL
IL-Z2Ra	NULL
«	NULL
gene	NULL
to	NULL
IL-1	NULL
,	NULL
which	NULL
is	NULL
completely	NULL
blocked	NULL
by	NULL
PDTC	NULL
,	NULL
while	NULL
AP-1	NULL
may	NULL
act	NULL
in	NULL
a	NULL
later	NULL
response	NULL
phase	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
the	NULL
strong	NULL
homology	NULL
between	NULL
the	NULL
promoter	NULL
proximal	NULL
regions	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
IL-2Ra	NULL
genes	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
SRF	NULL
and	NULL
Spl	NULL
(	NULL
GC-box	NULL
)	NULL
that	NULL
are	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
human	NULL
gene	NULL
and	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
its	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
response	NULL
(	NULL
19	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
are	NULL
not	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
.	NULL

The	NULL
sequence	NULL
called	NULL
NF	NULL
IL-2RA	NULL
or	NULL
UE-1	NULL
(	NULL
19	NULL
,	NULL
44	NULL
)	NULL
is	NULL
partially	NULL
con-served	NULL
,	NULL
but	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
has	NULL
not	NULL
been	NULL
sufficiently	NULL
well	NULL
characterized	NULL
to	NULL
determine	NULL
whether	NULL
their	NULL
binding	NULL
site	NULL
is	NULL
present	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
.	NULL

IL-2	NULL
Responsiveness	NULL
of	NULL
the	NULL
Mouse	NULL
IL-2Ra	NULL
Gene	NULL
Depends	NULL
on	NULL
Three	NULL
Closely	NULL
Spaced	NULL
Elements	NULL
1.3	NULL
kb	NULL
Upstream	NULL
of	NULL
the	NULL
Transcription	NULL
Start	NULL
Site-None	NULL
of	NULL
the	NULL
deletions	NULL
in	NULL
segment	NULL
D	NULL
abolishes	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sites	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B2	NULL
in	NULL
deletion	NULL
AD2	NULL
does	NULL
not	NULL
significantly	NULL
affect	NULL
IL-2	NULL
inducibility	NULL
.	NULL

Since	NULL
a	NULL
computer	NULL
search	NULL
revealed	NULL
no	NULL
additional	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
segments	NULL
A-D	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

6A	NULL
for	NULL
search	NULL
conditions	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
a	NULL
direct	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
by	NULL
IL-2	NULL
.	NULL

Even	NULL
pRAD3	NULL
in	NULL
which	NULL
all	NULL
IL-1	NULL
response	NULL
elements	NULL
have	NULL
been	NULL
removed	NULL
is	NULL
still	NULL
significantly	NULL
stimulated	NULL
by	NULL
IL-2	NULL
.	NULL

This	NULL
result	NULL
implies	NULL
that	NULL
IL-l-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
10751	NULL
STIMULUS	NULL
:	NULL
{	NULL
ict	NULL
N	NULL
i12	NULL
Q	NULL
i1+1L2	NULL
.	NULL

60.	NULL
.	NULL

9	NULL
.	NULL

£C	NULL
=	NULL
C	NULL
c	NULL
a	NULL
p	NULL
8	NULL
*to	NULL
do	NULL
i	NULL
Oi	NULL
i	NULL
ib	NULL
g	NULL
a	NULL
a	NULL
A.	NULL
a.	NULL
a.	NULL
a.	NULL
Plasmid	NULL
IL-2Ra	NULL
gene	NULL
is	NULL
not	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2-responsive	NULL
elements	NULL
in	NULL
segment	NULL
C.	NULL
It	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
segment	NULL
C3	NULL
acts	NULL
as	NULL
an	NULL
IL-2-responsive	NULL
enhancer	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
that	NULL
can	NULL
not	NULL
be	NULL
stimulated	NULL
with	NULL
IL-1	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
reduced	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
plasmids	NULL
with	NULL
deletions	NULL
in	NULL
the	NULL
promoter	NULL
proximal	NULL
region	NULL
(	NULL
particularly	NULL
pADS	NULL
,	NULL
pAD3	NULL
,	NULL
and	NULL
pAD6	NULL
)	NULL
suggests	NULL
that	NULL
maximal	NULL
activity	NULL
of	NULL
the	NULL
IL-2-responsive	NULL
elements	NULL
in	NULL
segment	NULL
C3	NULL
does	NULL
depend	NULL
on	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
itself	NULL
.	NULL

Using	NULL
IL-1	NULL
primed	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
elements	NULL
in	NULL
segment	NULL
C	NULL
that	NULL
are	NULL
strictly	NULL
required	NULL
for	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
map	NULL
to	NULL
a	NULL
48-bp	NULL
segment	NULL
1.3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Elsewhere	NULL
(	NULL
65	NULL
)	NULL
we	NULL
show	NULL
that	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
,	NULL
a	NULL
DNase	NULL
I-hypersensitive	NULL
site	NULL
appears	NULL
at	NULL
this	NULL
position	NULL
when	NULL
cells	NULL
are	NULL
stimulated	NULL
to	NULL
express	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

This	NULL
provides	NULL
completely	NULL
independent	NULL
evidence	NULL
for	NULL
an	NULL
important	NULL
regulatory	NULL
role	NULL
of	NULL
this	NULL
segment	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
three	NULL
separate	NULL
elements	NULL
within	NULL
the	NULL
48-bp	NULL
segment	NULL
are	NULL
required	NULL
for	NULL
full	NULL
IL-2	NULL
responsiveness	NULL
.	NULL

Site	NULL
I	NULL
(	NULL
defined	NULL
by	NULL
mutations	NULL
M4-M6	NULL
)	NULL
contains	NULL
a	NULL
nucleotide	NULL
sequence	NULL
that	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
core	NULL
of	NULL
the	NULL
GAS-1	NULL
element	NULL
in	NULL
the	NULL
tryptophanyl-tRNA	NULL
synthetase	NULL
gene	NULL
.	NULL

This	NULL
sequence	NULL
binds	NULL
several	NULL
cytokine-inducible	NULL
members	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

Since	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
IL-2	NULL
can	NULL
activate	NULL
STAT	NULL
proteins	NULL
that	NULL
recognize	NULL
similar	NULL
motifs	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
site	NULL
I	NULL
is	NULL
the	NULL
target	NULL
of	NULL
such	NULL
a	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
band	NULL
shift	NULL
and	NULL
footprint-ing	NULL
experiments	NULL
with	NULL
PC6O	NULL
nuclear	NULL
extracts	NULL
have	NULL
not	NULL
yet	NULL
revealed	NULL
any	NULL
IL-2-inducible	NULL
DNA-binding	NULL
proteins	NULL
specific	NULL
for	NULL
sequences	NULL
in	NULL
C3	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
site	NULL
II	NULL
(	NULL
defined	NULL
by	NULL
mutation	NULL
M9	NULL
)	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
site	NULL
I	NULL
and	NULL
may	NULL
also	NULL
be	NULL
a	NULL
target	NULL
of	NULL
an	NULL
IL-2-induced	NULL
STAT	NULL
protein	NULL
.	NULL

But	NULL
it	NULL
includes	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
for	NULL
factors	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
,	NULL
a	NULL
member	NULL
of	NULL
which	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell-specific	NULL
gene	NULL
expression	NULL
(	NULL
51-53	NULL
)	NULL
.	NULL

Site	NULL
III	NULL
(	NULL
defined	NULL
by	NULL
mutations	NULL
M12	NULL
and	NULL
M13	NULL
)	NULL
forms	NULL
part	NULL
of	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factor	NULL
Ets-1	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
consensus	NULL
site	NULL
extends	NULL
into	NULL
the	NULL
nucleotides	NULL
altered	NULL
in	NULL
M14	NULL
,	NULL
but	NULL
this	NULL
mutation	NULL
is	NULL
compatible	NULL
with	NULL
Ets-1	NULL
binding	NULL
.	NULL

Site	NULL
III	NULL
overlaps	NULL
with	NULL
a	NULL
DNase	NULL
I	NULL
footprint	NULL
over	NULL
position	NULL
-1331	NULL
to	NULL
-1314	NULL
that	NULL
is	NULL
obtained	NULL
with	NULL
extracts	NULL
from	NULL
induced	NULL
as	NULL
well	NULL
as	NULL
nonstimulated	NULL
PC6O	NULL
cells	NULL
.	NULL
``	NULL

Further	NULL
work	NULL
is	NULL
required	NULL
to	NULL
definitively	NULL
identify	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
confer	NULL
IL-2	NULL
responsiveness	NULL
to	NULL
the	NULL
C3	NULL
segment	NULL
,	NULL
and	NULL
to	NULL
define	NULL
their	NULL
role	NULL
in	NULL
this	NULL
response	NULL
.	NULL

We	NULL
also	NULL
plan	NULL
to	NULL
explore	NULL
whether	NULL
the	NULL
finding	NULL
that	NULL
significant	NULL
IL-2	NULL
responsiveness	NULL
requires	NULL
three	NULL
distinct	NULL
but	NULL
closely	NULL
spaced	NULL
elements	NULL
is	NULL
a	NULL
reflection	NULL
of	NULL
some	NULL
form	NULL
of	NULL
direct	NULL
cooperation	NULL
between	NULL
the	NULL
proteins	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

Stimulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
transcription	NULL
by	NULL
IL-2	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
human	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
proteins	NULL
and	NULL
°	NULL
M.	NULL
Pla	NULL
,	NULL
P.	NULL
Sperisen	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

10752	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
-	NULL
54	NULL
x8	NULL
-	NULL
585	NULL
-1319	NULL
-1366	NULL
-A	NULL
CALI	NULL
_	NULL
P	NULL
Antigen	NULL
C	NULL
IL-1	NULL
_	NULL
&	NULL
TIME	NULL
TRANSCRIPTION	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
gene	NULL
by	NULL
IL-1	NULL
(	NULL
or	NULL
antigen	NULL
)	NULL
and	NULL
IL-2	NULL
.	NULL

The	NULL
model	NULL
postulates	NULL
that	NULL
the	NULL
biphasic	NULL
response	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
to	NULL
stimulation	NULL
by	NULL
IL-1	NULL
and	NULL
IL-2	NULL
in	NULL
CD4~CD8~	NULL
thymocytes	NULL
or	NULL
to	NULL
antigen	NULL
and	NULL
IL-2	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
is	NULL
controlled	NULL
by	NULL
two	NULL
independently	NULL
functioning	NULL
sets	NULL
of	NULL
regulatory	NULL
elements	NULL
.	NULL

IL-1	NULL
or	NULL
antigen	NULL
activate	NULL
the	NULL
first	NULL
phase	NULL
of	NULL
transcription	NULL
via	NULL
promoter	NULL
proximal	NULL
elements	NULL
,	NULL
among	NULL
them	NULL
a	NULL
critical	NULL
NF-KB	NULL
site	NULL
.	NULL

Simul-taneously	NULL
,	NULL
these	NULL
signals	NULL
induce	NULL
cells	NULL
to	NULL
become	NULL
IL-2	NULL
responsive	NULL
,	NULL
and	NULL
thus	NULL
prime	NULL
them	NULL
for	NULL
the	NULL
second	NULL
phase	NULL
.	NULL

This	NULL
is	NULL
mediated	NULL
by	NULL
IL-2-responsive	NULL
elements	NULL
1.3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

sequence	NULL
elements	NULL
that	NULL
mediate	NULL
this	NULL
regulation	NULL
are	NULL
the	NULL
same	NULL
in	NULL
rodents	NULL
and	NULL
in	NULL
man	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
5-FR	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
until	NULL
position	NULL
-1241	NULL
has	NULL
been	NULL
published	NULL
.	NULL

The	NULL
two	NULL
genes	NULL
share	NULL
highly	NULL
homologous	NULL
promoter-proximal	NULL
regions	NULL
,	NULL
but	NULL
apart	NULL
from	NULL
homology	NULL
between	NULL
repetitive	NULL
Alu	NULL
and	NULL
B1	NULL
elements	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4A	NULL
for	NULL
repetitive	NULL
elements	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
)	NULL
there	NULL
is	NULL
no	NULL
significant	NULL
similarity	NULL
upstream	NULL
of	NULL
position	NULL
-335	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
.	NULL

Recombinants	NULL
between	NULL
the	NULL
-1241/+93	NULL
segment	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
«	NULL
and	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
stimulation	NULL
with	NULL
IL-2	NULL
in	NULL
PC6O	NULL
cells	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
human	NULL
IL-2	NULL
response	NULL
elements	NULL
do	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
present	NULL
in	NULL
the	NULL
part	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
which	NULL
sequence	NULL
data	NULL
have	NULL
been	NULL
published	NULL
.	NULL

IL-2	NULL
has	NULL
the	NULL
characteristics	NULL
of	NULL
a	NULL
progression	NULL
factor	NULL
,	NULL
in	NULL
that	NULL
it	NULL
stimulates	NULL
the	NULL
proliferation	NULL
of	NULL
``	NULL
competent	NULL
``	NULL
,	NULL
IL-2-responsive	NULL
lymphocytes	NULL
(	NULL
55-57	NULL
)	NULL
.	NULL

In	NULL
PC6O	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
on	NULL
IL-Z2Ra	NULL
expression	NULL
is	NULL
uncoupled	NULL
from	NULL
the	NULL
growth	NULL
factor	NULL
activity	NULL
of	NULL
IL-2	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
leading	NULL
from	NULL
the	NULL
IL-2	NULL
receptor	NULL
to	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
is	NULL
different	NULL
from	NULL
the	NULL
one	NULL
that	NULL
drives	NULL
cells	NULL
into	NULL
S-phase	NULL
.	NULL

It	NULL
may	NULL
overlap	NULL
with	NULL
the	NULL
pathways	NULL
that	NULL
mediate	NULL
IL-2	NULL
stimulation	NULL
of	NULL
granzyme	NULL
and	NULL
per-forin	NULL
expression	NULL
(	NULL
28	NULL
,	NULL
58	NULL
)	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
IL-2	NULL
stimulates	NULL
IgJ-chain	NULL
expression	NULL
(	NULL
59	NULL
)	NULL
.	NULL

IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
J-chain	NULL
gene	NULL
depends	NULL
on	NULL
a	NULL
28-bp	NULL
stretch	NULL
between	NULL
position	NULL
-74	NULL
and	NULL
-41	NULL
(	NULL
60	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
has	NULL
no	NULL
significant	NULL
similarity	NULL
with	NULL
segment	NULL
C	NULL
,	NULL
suggesting	NULL
that	NULL
IL-2	NULL
stimulates	NULL
IgJ	NULL
expression	NULL
via	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
General	NULL
Model	NULL
for	NULL
the	NULL
Regulation	NULL
of	NULL
IL-2Ra	NULL
Gene	NULL
Tran-scription-The	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
are	NULL
summarized	NULL
in	NULL
the	NULL
model	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

They	NULL
show	NULL
that	NULL
the	NULL
complex	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
gene	NULL
in	NULL
CD4~CDS8S~	NULL
thymocytes	NULL
to	NULL
IL-1	NULL
+	NULL
IL-2	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
existence	NULL
of	NULL
two	NULL
sets	NULL
of	NULL
cis-acting	NULL
elements	NULL
.	NULL

Promoter	NULL
proximal	NULL
elements	NULL
,	NULL
among	NULL
which	NULL
a	NULL
conserved	NULL
NF-KB	NULL
site	NULL
plays	NULL
a	NULL
dominant	NULL
role	NULL
,	NULL
mediate	NULL
an	NULL
early	NULL
response	NULL
that	NULL
is	NULL
stimulated	NULL
by	NULL
IL-1	NULL
alone	NULL
.	NULL

IL-1	NULL
also	NULL
increases	NULL
IL-2	NULL
responsiveness	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
augmenting	NULL
the	NULL
number	NULL
of	NULL
functional	NULL
IL-2R	NULL
.	NULL

IL-2	NULL
induces	NULL
the	NULL
second	NULL
phase	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
complex	NULL
Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
enhancer	NULL
1.3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
biphasic	NULL
response	NULL
correlates	NULL
with	NULL
a	NULL
bipartite	NULL
structure	NULL
of	NULL
5'-FR	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
the	NULL
model	NULL
presented	NULL
here	NULL
also	NULL
applies	NULL
to	NULL
the	NULL
antigen-triggered	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
«	NULL
expression	NULL
in	NULL
mature	NULL
lymphocytes	NULL
and	NULL
that	NULL
antigen	NULL
plays	NULL
a	NULL
similar	NULL
role	NULL
to	NULL
IL-1	NULL
.	NULL

Stimulation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
antigen	NULL
or	NULL
anti-CD3	NULL
induces	NULL
activation	NULL
of	NULL
NF-kB	NULL
,	NULL
and	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
antigen-induced	NULL
increase	NULL
in	NULL
IL-2Ra	NULL
mRNA	NULL
in	NULL
a	NULL
CD8*	NULL
T	NULL
cell	NULL
clone	NULL
shows	NULL
the	NULL
same	NULL
sensitivity	NULL
to	NULL
inhibition	NULL
by	NULL
PDTC	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL
``	NULL

In	NULL
the	NULL
same	NULL
clone	NULL
,	NULL
IL-2Ra	NULL
mRNA	NULL
levels	NULL
return	NULL
to	NULL
base	NULL
line	NULL
24	NULL
h	NULL
after	NULL
exposure	NULL
to	NULL
antigen	NULL
unless	NULL
IL-2	NULL
is	NULL
added	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
maximal	NULL
and	NULL
prolonged	NULL
expression	NULL
of	NULL
both	NULL
the	NULL
normal	NULL
IL-2Ra	NULL
gene	NULL
and	NULL
a	NULL
IL-2Ra	NULL
5'-FR/	NULL
chloramphenicol	NULL
acetyltransferase	NULL
transgene	NULL
in	NULL
concanavalin	NULL
A-stimulated	NULL
peripheral	NULL
T	NULL
cells	NULL
depends	NULL
on	NULL
IL-2	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
GLAXO	NULL
for	NULL
the	NULL
generous	NULL
gifts	NULL
of	NULL
interleukin	NULL
1	NULL
and	NULL
2	NULL
.	NULL

We	NULL
thank	NULL
Tasuku	NULL
Honjo	NULL
for	NULL
the	NULL
IL-2Ra	NULL
genomic	NULL
and	NULL
cDNA	NULL
clones	NULL
and	NULL
Guido	NULL
Miescher	NULL
for	NULL
the	NULL
mouse	NULL
B-actin	NULL
construct	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Charles	NULL
Weissman	NULL
and	NULL
Pierre	NULL
Chambon	NULL
for	NULL
plasmids	NULL
Z-pCRI/pRChr	NULL
$	NULL
G-1	NULL
and	NULL
pG1	NULL
;	NULL
Claudine	NULL
Ravussin	NULL
,	NULL
Pierre	NULL
Dubied	NULL
,	NULL
and	NULL
Marcel	NULL
Allegrini	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
figures	NULL
;	NULL
and	NULL
Bernhard	NULL
Hirt	NULL
for	NULL
useful	NULL
suggestions	NULL
and	NULL
criticisms	NULL
concerning	NULL
the	NULL
manuscript	NULL
.	NULL

Note	NULL
Added	NULL
in	NULL
Proof-Recently	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
(	NULL
66	NULL
)	NULL
that	NULL
an	NULL
Elf-1	NULL
binding	NULL
site	NULL
around	NULL
bp	NULL
92	NULL
in	NULL
the	NULL
human	NULL
IL-2R	NULL
«	NULL
gene	NULL
is	NULL
important	NULL
for	NULL
its	NULL
response	NULL
to	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

This	NULL
site	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
mouse	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Asao	NULL
,	NULL
H.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
4127-4131	NULL
.	NULL

Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58	NULL
,	NULL
875-911	NULL
.	NULL

Pimentel-Muinos	NULL
,	NULL
F.	NULL
X.	NULL
,	NULL
Munoz-Fernandez	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
5714-5722	NULL
4	NULL
.	NULL

Erard	NULL
,	NULL
F.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
Conzelmann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160	NULL
,	NULL
584-599	NULL
5	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
864-868	NULL
6	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Howe	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Ceredig	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

187	NULL
,	NULL
2579-2584	NULL
7	NULL
.	NULL

Bismuth	NULL
,	NULL
G.	NULL
,	NULL
Moreau	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Sommé	NULL
,	NULL
G.	NULL
,	NULL
Duphot	NULL
,	NULL
M.	NULL
,	NULL
Dautry	NULL
Varsat	NULL
,	NULL
A.	NULL
,	NULL
Robb	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Théze	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

15	NULL
,	NULL
728-727	NULL
.	NULL

Malek	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Ashwell	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161	NULL
,	NULL
1575-1580	NULL
.	NULL

Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Drogula	NULL
,	NULL
C.	NULL
,	NULL
Krinke	NULL
,	NULL
M.	NULL
,	NULL
Waldmann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
4230-4234	NULL
10	NULL
.	NULL

Wilson	NULL
,	NULL
A.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
1729-1735	NULL
11	NULL
.	NULL

Plaetinck	NULL
,	NULL
G.	NULL
,	NULL
Combe	NULL
,	NULL
M.-C.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Sperisen	NULL
,	NULL
P.	NULL
,	NULL
Kanamori	NULL
,	NULL
H.	NULL
,	NULL
Honjo	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
3340-3347	NULL
12	NULL
.	NULL

Krinke	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161	NULL
,	NULL
1593-1598	NULL
13	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
2331-2335	NULL
14	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A.	NULL
B5	NULL
,	NULL
4468-4472	NULL
15	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
388	NULL
,	NULL
776-778	NULL
16	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
466-469	NULL
17	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
850-853	NULL
18	NULL
.	NULL

Freimuth	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Depper	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3064-3068	NULL
19	NULL
.	NULL

Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Halden	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
1830-1834	NULL
20	NULL
.	NULL

Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
642-647	NULL
21	NULL
.	NULL

Conzelmann	NULL
,	NULL
A.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Cianfriglia	NULL
,	NULL
M.	NULL
,	NULL
Silva	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1982	NULL
)	NULL
Nature	NULL
298	NULL
,	NULL
170-172	NULL
22	NULL
.	NULL

Silva	NULL
,	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Conzelmann	NULL
,	NULL
A.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

76	NULL
,	NULL
105-129	NULL
23	NULL
.	NULL

Espel	NULL
,	NULL
E.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
929-937	NULL
24	NULL
.	NULL

Plaetinck	NULL
,	NULL
G.	NULL
,	NULL
Combe	NULL
,	NULL
M.-C.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Seckinger	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19	NULL
,	NULL
897-904	NULL
25	NULL
.	NULL

Geering	NULL
,	NULL
G.	NULL
,	NULL
Old	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Boyse	NULL
,	NULL
E.	NULL
(	NULL
1966	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

124	NULL
,	NULL
753-772	NULL
26	NULL
.	NULL

Gough	NULL
,	NULL
N.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

178	NULL
,	NULL
93-95	NULL
27	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
28	NULL
.	NULL

Garcia	NULL
Sanz	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Jenne	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Tschopp	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
3111-3118	NULL
go	NULL
bo	NULL
w	NULL
co	NULL
*P.	NULL
Reichenbach	NULL
and	NULL
M.	NULL
Nabholz	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

°	NULL
S.	NULL
Barangé	NULL
and	NULL
M.	NULL
Nabholz	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

29	NULL
.	NULL

80	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

87	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Bipartite	NULL
Structure	NULL
of	NULL
Mouse	NULL
IL-2Ra	NULL
5'-Flanking	NULL
Region	NULL
Suzuki	NULL
,	NULL
N.	NULL
,	NULL
Matsunami	NULL
,	NULL
N.	NULL
,	NULL
Kanamori	NULL
,	NULL
H.	NULL
,	NULL
Ishida	NULL
,	NULL
N.	NULL
,	NULL
Shimizu	NULL
,	NULL
A.	NULL
,	NULL
Yavita	NULL
,	NULL
Y.	NULL
,	NULL
Nikaido	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
5079-5086	NULL
Devereux	NULL
,	NULL
J.	NULL
,	NULL
Haeberli	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Smithies	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
387-395	NULL
Bucher	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

212	NULL
,	NULL
563-578	NULL
Altschul	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Gish	NULL
,	NULL
W.	NULL
,	NULL
Miller	NULL
,	NULL
W.	NULL
,	NULL
Myers	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Lipman	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

215	NULL
,	NULL
403-410	NULL
Pearson	NULL
,	NULL
W.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

183	NULL
,	NULL
63-98	NULL
Sperisen	NULL
,	NULL
P.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
PCR	NULL
Methods	NULL
Applications	NULL
1	NULL
,	NULL
164-170	NULL
van	NULL
den	NULL
Berg	NULL
,	NULL
J.	NULL
,	NULL
van	NULL
Ooyen	NULL
,	NULL
A.	NULL
,	NULL
Mantei	NULL
,	NULL
N.	NULL
,	NULL
Schambick	NULL
,	NULL
A.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
Flavell	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Weissmann	NULL
,	NULL
C.	NULL
(	NULL
1978	NULL
)	NULL
Nature	NULL
276	NULL
,	NULL
37-44	NULL
Kunkel	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Zakour	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

154	NULL
,	NULL
367-382	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
336	NULL
,	NULL
692-695	NULL
Queen	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
88	NULL
,	NULL
741-748	NULL
Kost	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Theodorakis	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hughes	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
8287-8301	NULL
Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
141-179	NULL
Lattion	NULL
,	NULL
A.-L.	NULL
,	NULL
Espel	NULL
,	NULL
E.	NULL
,	NULL
Reichenbach	NULL
,	NULL
P.	NULL
,	NULL
Bucher	NULL
,	NULL
P.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Israel	NULL
,	NULL
A.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
5217-5227	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2247-2258	NULL
Pomerantz	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Mauxion	NULL
,	NULL
F.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

1438	NULL
,	NULL
4275-4281	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Hoffman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Dixon	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
83-92	NULL
Feldman	NULL
,	NULL
M.	NULL
,	NULL
Nabholz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bodmer	NULL
,	NULL
W.	NULL
F.	NULL
(	NULL
1969	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

21	NULL
,	NULL
171-193	NULL
Strehlow	NULL
,	NULL
I.	NULL
,	NULL
Seegert	NULL
,	NULL
D.	NULL
,	NULL
Frick	NULL
,	NULL
C.	NULL
,	NULL
Bange	NULL
,	NULL
F.-C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Bottger	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
16590-16595	NULL
Seegert	NULL
,	NULL
D.	NULL
,	NULL
Strehlow	NULL
,	NULL
I.	NULL
,	NULL
Klose	NULL
,	NULL
B.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
8590-8595	NULL
Eilers	NULL
,	NULL
A.	NULL
,	NULL
Baccarini	NULL
,	NULL
M.	NULL
,	NULL
Horn	NULL
,	NULL
F.	NULL
,	NULL
Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Decker	NULL
,	NULL
49	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

107583	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1364-1373	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
Guschin	NULL
,	NULL
D.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Kerr	NULL
,	NULL
L	NULL
M.	NULL
,	NULL
and	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5605-5615	NULL
Gilbour	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
,	NULL
Sci	NULL
.	NULL

U	NULL
.	NULL

S	NULL
,	NULL
A	NULL
.	NULL

91	NULL
,	NULL
6850-6854	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Bories	NULL
,	NULL
D.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Labastie	NULL
,	NULL
M.-C.	NULL
,	NULL
Chretien	NULL
,	NULL
S.	NULL
,	NULL
Mattéi	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Roméo	NULL
,	NULL
P.-H.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
.	NULL

J	NULL
.	NULL

10	NULL
,	NULL
1809-1816	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ting	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2778-2784	NULL
Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
Vorhees	NULL
,	NULL
P.	NULL
,	NULL
Marin	NULL
,	NULL
N.	NULL
,	NULL
Oakley	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Leiden	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
.	NULL

J	NULL
.	NULL

10	NULL
,	NULL
1187-1192	NULL
Bosselut	NULL
,	NULL
R.	NULL
,	NULL
Levin	NULL
,	NULL
J.	NULL
,	NULL
Adjadj	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5184-5191	NULL
Sekaly	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Zaech	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1982	NULL
)	NULL
J.	NULL
Immunol	NULL
,	NULL
129	NULL
,	NULL
1407-1415	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Tougne	NULL
,	NULL
C.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Nabholz	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

184	NULL
,	NULL
931-939	NULL
Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
224	NULL
,	NULL
1312-1316	NULL
Garcia-Sanz	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Podack	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
1877-1883	NULL
Tigges	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Casey	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
781-786	NULL
Lansford	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
McFadden	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Siu	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Cox	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Cann	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
5966-5970	NULL
Froussard	NULL
,	NULL
P.	NULL
,	NULL
Jankovic	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Chastagner	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Theze	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Immunol	NULL
.	NULL

28	NULL
,	NULL
87-93	NULL
Pollock	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6197-6204	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
8526-8530	NULL
Soldaini	NULL
,	NULL
E.	NULL
,	NULL
Pla	NULL
,	NULL
M.	NULL
,	NULL
Beermann	NULL
,	NULL
F.	NULL
,	NULL
Espel	NULL
,	NULL
E.	NULL
,	NULL
Corthésy	NULL
,	NULL
P.	NULL
,	NULL
Barangé	NULL
,	NULL
S.	NULL
,	NULL
Waanders	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Nabholz	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
10733-10742	NULL
John	NULL
,	NULL
S.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
Child	NULL
,	NULL
R.	NULL
,	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1786-1796	NULL

